FIDELITY ASIAN VALUES PLC
Final Results for the year ended 31 July
2023
Financial
Highlights:
-
The Board
of Fidelity Asian Values PLC (the “Company”) recommends an annual
dividend of 14.50 pence per
share.
-
The net
asset value (NAV) total return increased by 11.4% for the year
ended 31 July 2023, outperforming the
Company’s Comparative Index (MSCI All Countries ex Japan Small Cap
Index) which rose by 7.5% over the same period.
-
The
ordinary share price total return for the reporting year was an
increase of 17.3%.
-
The
Company maintains net gearing of approximately 4.9%, reflecting
opportunities found across the region.
Contacts
For further information, please
contact:
Nira Mistry
Company Secretary
FIL Investments International
07778 354517
Chairman’s Statement
This is my last Annual Report for the Company, having served as
your Chairman for nine years this December. During that time, your
Company has gone through significant changes. Having begun as a
large-cap Asia fund, it now
operates in a very different area, primarily investing in smaller
companies with a focus on value stocks. As I prepare to retire from
the Board, I have taken the opportunity to look back at the impact
of these changes, beginning with the selection of Nitin Bajaj as your Portfolio Manager in
April 2015. From Nitin’s appointment
until 31 July
2023, your Company has produced a Net Asset Value (“NAV”)
total return of 112.6% and a share price total return of 129.0%,
outperforming the Comparative Index (MSCI All Countries Asia ex
Japan Small Cap Index (net) total return (in sterling terms)) of
72.9% and also the peer group average total returns of 87.5% (NAV)
and 117.1% (share price). During this time, the discount to NAV has
narrowed from the mid-teens to low single digits (occasionally
trading at a premium, which is testament to a very clear and
well-supported investment proposition), and we have also been able
to deliver a significant increase in the dividend, both of which
have been to the long-term benefit of shareholders.
Coming back to the year just ended, it is pleasing to report a year
of strong performance, in which your Portfolio Manager’s strong
stock selection has been complemented by a market environment that
has favoured the Company’s quality and value-focused investment
approach. In the year to 31 July
2023, the NAV total return was 11.4%, while the Comparative
Index total return was 7.5% over the same period. After
experiencing negative performance in the last financial year, the
share price has rebounded strongly, producing a total return of
17.3% as the discount to NAV has narrowed from 9.8% at the start of
the year to 5.3% at the end. This is particularly notable given the
general widening in investment trust discounts during the year.
Nitin talks more on the drivers for the positive performance in his
Portfolio Manager’s Review below.
Due Diligence 2023
In March 2023, your Board took an
in-person due diligence trip to Asia for the first time since 2018. We
travelled first to Singapore,
where the portfolio management team is based, and spent time with
Nitin, Ajinkya Dhavale, who has now been the Assistant Portfolio
Manager of the Company for three years, and colleagues, including
Fidelity’s Head of Equities for the Asia
Pacific region. We also met with some locally based
companies to see how Fidelity’s meetings with them are run and how
they form part of the stock picking process. We then went to
South Korea for three days of
company visits. What stood out to us as a Board was the quality of
the management teams we met in Korea and the depth and calibre of
the businesses; although these companies are not the largest, their
global presence was really startling. One example was Hankook Tire,
a provider of e-vehicle tyres and a growing contributor to profits.
It has recently taken over from Michelin as the official supplier
for the Formula E motor racing competition. It was most interesting
to observe Nitin and Ajinkya as they interviewed companies, and to
see during a process of incisive questioning, the very obvious
mutual respect in which they hold both management and each other.
This really underpins our continued confidence in the team that
manages your – and our – investment in the Company.
Discount management and share
repurchases
After the spike in market volatility seen in the first half of 2022
when Russia invaded Ukraine, conditions continued to be unsettled
into the first half of the Company’s financial year ended
31 July 2023. Between August and
November 2022, the Board approved the
repurchase of 569,000 ordinary shares (0.8% of the issued share
capital) for holding in Treasury, at a cost of £2,618,000. Since
then and up to the date of this report, no shares have been
repurchased, given an encouraging narrowing of the Company’s
discount even as peers’ and broader investment trust average
discounts have widened.
Your Board closely monitors the Company’s share price discount to
NAV and will undertake active discount management where necessary,
the primary purpose of which is to limit discount volatility.
Repurchases of ordinary shares are made at the discretion of the
Board, within guidelines set by it and considering prevailing
market conditions. Shares will only be repurchased in the market at
prices below the prevailing NAV per ordinary share, thereby
resulting in an enhancement to the NAV per ordinary share. In order
to assist in managing the discount, the Board has shareholder
approval to hold in Treasury any ordinary shares repurchased by the
Company, rather than cancelling them. Any shares held in Treasury
would only be reissued at NAV per ordinary share or at a premium to
NAV per ordinary share.
Dividend
Your Portfolio Manager invests principally for capital growth, but
his value-oriented investment style tends to lead him towards
unleveraged, cash-generative businesses that may themselves be able
to pay rising dividends. As such, the Company’s revenue return was
15.17 pence per ordinary share (an
increase of 6.8% from the prior year revenue return of 14.21 pence per ordinary share). Last year your
Board declared a substantially increased dividend of 14.00 pence per share (2021: 8.80 pence). While we noted at the time that
shareholders should not assume that such dividends would continue
in the future, we are very pleased to be able to recommend another
increase in the dividend for 2023, to 14.50
pence per share which will be paid to shareholders on
6 December 2023. The Board is again
recommending that almost all of the income earned be paid out as a
dividend. We would reiterate, however, that income is an output
rather than an aim of the investment process, and that no
guarantees can be offered as to the level of any future
dividends.
Gearing
As I noted in last year’s Annual Report, the Company’s level of
gross gearing is directly proportional to the investment
opportunities that your Portfolio Manager sees. When Nitin is
optimistic about opportunities and he and his team generate ideas
in response to market conditions, then the Company will be more
geared. As such, it is notable that gearing during the year reached
the highest level we have seen during Nitin’s tenure, ending the
year with gross gearing at 11.7%, up from 4.4% as at 31 July 2022; net gearing was 4.9% (2022: nil).
As Nitin notes in his review below, gearing has been increased
largely in response to a number of particularly interesting
investment opportunities in China,
which have been out of favour with investors. The Company’s gearing
is achieved using contracts for difference (“CFDs”); we have no
bank borrowings or structural long-term debt. We regularly review
the use of CFDs and have again concluded that they remain a more
efficient and flexible form of financing than either secured or
unsecured debt, as well as enabling your Portfolio Manager to be
fleet of foot in the deployment of gearing. We are fortunate that
Fidelity has the infrastructure and capability to allow the use of
CFDs in the portfolio; few other management groups can offer
this.
Use of Short positions
A few years ago, the Board approved giving your Portfolio Manager
the ability to ‘short’ stocks, and we are pleased to report that
this approach is adding value and has been a positive contributor
during the year. A short position is taken on the view that the
price of a stock or the value of an index will go down rather than
up. Ajinkya has extensive experience in shorting, and Nitin is
encouraged by the availability of such opportunities in the market
today, given a real disparity between the prospects of the smaller
value stocks that he favours and some of the large and mega-cap
stocks in Asia that he thinks are
vulnerable. Short positions are limited to a maximum of 10% of the
portfolio and do not usually exceed ten stocks. While there is no
intention to increase the limit, the combination of Ajinkya’s (and
Fidelity’s) competence and the current market environment means
that Nitin may maintain and even opportunistically increase the
short exposure, within the investment limits. Total short exposure
as at 31 July 2023 was 3.4% (2022:
2.2%).
Environmental, Social & Governance
(ESG)
There has been something of an ESG backlash in recent times. Your
Company is not an ‘ESG fund’, but good governance and social
behaviour and a strong regard for the environment have always been
fundamental to the way Nitin invests. Assessing ESG in Asia can be quite different from that in
developed economies. Smaller Asian companies may not have the
resources to report on ESG as companies do in the West, so the
strength and depth of Fidelity’s large analyst team in the region
is invaluable in making properly thought-through assessments in the
process, both on a fundamental and an ESG basis.
In the Portfolio Manager’s Review, Nitin shares the example of
Shriram Finance as a position that has not only added value to the
portfolio, but is also a well-governed company doing social good as
well as mitigating environmental impact. Shriram Finance was formed
from the merger of two companies offering affordable finance on
used commercial vehicles and two-wheelers. It serves communities
and micro, small and medium enterprises that would otherwise face
high interest costs from unregulated lending, enabling them to grow
their businesses without the unaffordable expense or the
environmental impact of scrapping old vehicles and building new
ones.
Board of Directors and Board Succession
Grahame Stott, having served nine
years on the Board, retired as a non-executive Director and
Chairman of the Audit Committee at the Company’s AGM in
November 2022. At the same time, we
welcomed Hussein Barma as a new
non-executive Director and Chairman of the Audit Committee. Hussein
is both a qualified lawyer and a chartered accountant and has
considerable experience in the listed company sector in the UK and
long familiarity with Asia, as
well as a good eye for detail. Clare
Brady will be stepping up as Chairman as I step down and
will continue to bring her invaluable experience and skills to the
Board. She will be replaced as Senior Independent Director by
Matthew Sutherland.
As noted in last year’s Annual Report, Michael Warren will shortly have served nine
years on the Board, but as part of the Board’s succession plan, he
has agreed to stay on until the 2024 AGM in order to ensure a good
handover of the institutional and historical knowledge of the
Company. We have already begun the process of selecting his
replacement and will make a further announcement in due course. We
will continue to maintain a Board with a diversity of backgrounds
and an appropriate mix of skills to ensure the Company’s continued
good governance.
Market outlook
The outlook for financial markets globally remains uncertain in
light of the ongoing war in Ukraine and US/China tensions. However, while the Western
world continues to struggle with the highest levels of inflation
and interest rates in nearly a generation, in many Asian markets,
the economic environment is very different, and on a relative basis
there are particularly good opportunities compared to the West. The
structural case for investing in developing economies remains
extremely strong: attractive demographics, a burgeoning middle
class providing new markets for goods and services, and economies
that can grow more rapidly. This is the backdrop against which your
Portfolio Manager looks to buy companies, but it is not what drives
the investment process, which is fundamentally to buy good
companies, run by good people and at attractive valuations. As we
enter our new financial year, Nitin continues to find good
companies he wants to buy and I am therefore optimistic that this,
combined with a positive market backdrop in Asia will continue to provide opportunities
for investors in the coming year.
I wish him, the team and the Board every success for the future and
would also like to thank all our shareholders for their continued
support.
Annual General Meeting
The AGM of the Company will be held at 11.00
am on Wednesday, 29 November
2023 at 4 Cannon Street, London EC4M 5AB (nearest tube stations are St
Paul’s or Mansion House) and virtually via the online Lumi AGM
meeting platform. Full details of the meeting are given in the
Notice of Meeting
in the Annual Report.
For those shareholders who are unable to attend in person, we will
live-stream the formal business and presentations of the meeting
online.
Nitin Bajaj, the Portfolio Manager,
will be making a presentation to shareholders highlighting the
achievements and challenges of the year past and the prospects for
the year to come. He and the Board will be very happy to answer any
questions that shareholders may have. Copies of his presentation
can be requested by email at
investmenttrusts@fil.com
or in writing to the Secretary at FIL Investments International,
Beech Gate, Millfield Lane, Lower
Kingswood, Tadworth, Surrey KT20
6RP.
Properly registered shareholders joining the AGM virtually, will be
able to vote on the proposed resolutions. Please see Note 9 to the
Notes to the Notice of Meeting in the Annual Report for details on
how to vote virtually. Investors viewing the AGM online will be
able to submit live written questions to the Board and the
Portfolio Manager and we will answer as many of these as possible
at an appropriate juncture during the meeting.
Further information and links to the Lumi platform may be found on
the Company’s website at
www.fidelity.co.uk/asianvalues.
On the day of the AGM, in order to join electronically and ask
questions via the Lumi platform, shareholders will need to connect
to the website
https://web.lumiagm.com.
Please note that investors on platforms, such as Fidelity Personal
Investing, Hargreaves Lansdown, Interactive Investor or AJ Bell
Youinvest, will need to request attendance at the AGM in accordance
with the policies of your chosen platform. They may request that
you submit electronic votes in advance of the meeting. If you are
unable to obtain a unique IVC and PIN from your nominee or
platform, we would welcome your online participation as a guest.
Once you have accessed https://web. lumiagm.com from your web
browser on a tablet or computer, you will need to enter the
Lumi Meeting ID
which is
109-975-634.
You should then select the ‘Guest Access’ option before entering
your name and who you are representing, if applicable. This will
allow you to view the meeting and ask questions, but you will not
be able to vote.
Kate
Bolsover
Chairman
11 October 2023
Portfolio
Manager’s Review
Question
How has the investment Company performed in the year to
31 July 2023?
Answer
Over the year ended 31 July 2023, the
Company’s net asset value (“NAV”) total return was +11.4%,
outperforming the Comparative Index, the MSCI All Countries Asia ex
Japan Small Cap Index (net) total return (in sterling terms) which
rose by +7.5%. The share price total return for the year was +17.3%
due to a narrowing of the Company’s discount.
Performance for the reporting year can be attributed primarily to
stock picking, with our country allocation being a headwind to
performance.
Our investment process is driven by owning good businesses which
are run by management teams whom we trust and investing in them
only when we have ample margin of safety. This often leads us to
take contrarian positions as it is easier to find undervalued
businesses in countries which are out of favour with investors.
Following this philosophy, we have a significant percentage of the
Company’s portfolio in China and
are underweight in Taiwan and
India compared to the Index.
Accordingly, while country selection would be a headwind to
performance, this was more than offset by good stock selection in
line with our investment philosophy, especially in our three key
markets of China, India and Indonesia.
Over the longer-term (since 2015 when the Board changed the
strategy of the Company to invest more in smaller companies), the
NAV (post fees) has risen by +112.6% versus the MSCI All Countries
Asia ex Japan Small Cap Index’s (net) total return of +72.9% and
the MSCI Asia ex Japan Large Cap Index’s total return of +62.2%,
both in sterling terms.
Question
China’s reopening from COVID lockdowns has had a
significant impact on the performance of global markets this year.
How do you feel about China and
the economic recovery?
Answer
When China reopened, there was a
lot of optimism in the market, but it turned out that the recovery
has been uneven and softer than expected in many areas. The
property downcycle, geopolitics, the reining in of local government
spending and increasing centralisation of political power has
resulted in China being one of the
few markets where profitability has not recovered post COVID.
Consequently, there is a heightened perception of risks around
Chinese companies, leading to a decline in stock prices. We agree
with some of the reasons for negative sentiment around China and understand that it is difficult to
predict when the economy will turn around.
However, we should also be cognisant of the strengths of the
country’s economy, its people and its businesses. It is the second
largest economy in the world and consumption is expanding as a
share of its GDP. It houses a significant part of the global supply
chains of most products we use in our daily lives. Hence, we feel
that these negative macro factors are transitory (as they were in
the US post the housing crises of 2007-10 or in India post the policy paralysis of 2012-13).
Good businesses will not only survive but are likely to be in a
stronger competitive position post this downturn and by taking
market share from their weaker peers. This is probably the best
time to be investing in China as
we are able to buy good businesses when both expectations and
valuations are low.
Thus, there are good opportunities in China at the moment, which in turn has seen
our combined exposure to China and
Hong Kong increase to about
38%.
Question
Looking beyond China,
where do you see value in stocks in the Asian region and how are
you reflecting this in the Company’s portfolio?
Answer
Our investments are based on our bottom-up fundamental analysis of
companies and their businesses and our exposure to countries is
primarily a result of our stock selection.
Looking at the portfolio beyond China, we are excited about the opportunities
we see in Indonesia (around 14%
exposure). Our holdings there are a mix of banks and
consumer-facing companies which are best-in-class operators with
high Returns on Equity (“ROEs”) and reasonable valuations. For
example, we own shares in two banks - Bank Mandiri (Persero) and
Bank Negara Indonesia (Persero). The former has seen a sustained
improvement in asset quality through better underwriting and risk
management since 2016 under a new management, while the latter is
going through restructuring with the same team of people who turned
around Bank Mandiri (Persero). The portfolio is invested in the
country’s leading ceramic tiles manufacturer Arwana Citramulia, a
business with long-term growth potential and a strong management
team. Among a few other positions, we also have exposure to the
country’s KFC master franchisee, Fastfood Indonesia, which again
has structural growth opportunity to expand as well as enhance
operational efficiencies.
In India, while it has not been
easy to find businesses with a suitable margin of safety, we are
still able to identify specific stocks that fit our criteria. Our
positions in India centre around
financial sector companies as they are growing more quickly, have
strong balance sheets and are available at prices which offer a
good margin of safety.
We
have studied these businesses for over 15 years and trust the
management teams who have delivered substantial shareholder value
over time.
Question
Your mandate is to look for smaller companies to invest in.
Can you give some examples of how smaller companies
outperform?
Answer
We invest in a subset of these smaller companies – in what are
popularly called ‘value’ stocks. Value stocks are classified as
companies that are currently trading below what they are worth and
are thus expected to provide superior returns. Almost 80% of the
portfolio is invested in companies which fit this
description.
As shown in the charts in the Annual Report, over the long-term,
this has been an attractive place to invest as small value stocks
have grown earnings faster than the market and hence have delivered
superior returns.
Despite this performance, the cohort of small value companies
continues to trade at a significant discount to the rest of the
market and looks very attractive today.
Question
How has the Company’s portfolio’s exposure to unlisted
companies changed during the year under review?
Answer
We have not added or sold any unlisted securities in the past year.
It continues to be a small part of the portfolio at less than 0.5%
of the Company’s invested assets. We believe that there are
sufficient opportunities in the listed space in Asia and, therefore, would only want to invest
in an unlisted company in exceptional circumstances.
Question
You have increased gearing within the Company’s portfolio
in the reporting year. What is the reason behind
this?
Answer
We have always maintained that gearing is a function of the number
of investment ideas we find. The level of gearing increases when we
find more ideas to invest in than we have money and it reduces (or
we keep a higher cash balance) when we do not find as many
ideas.
Over the past year, gearing has increased as we have found
particularly interesting investments in China given the market has fallen out of
favour. At the year end, gross gearing was 11.7% (2022: 4.4%) and
net gearing was 4.9% (2022: nil). See the charts in the Annual
Report on the Company’s gearing history over my tenure.
Question
The rising cost of living continues to pressure consumers.
How has higher inflation and rising interest rates impacted Asian
markets?
Answer
Inflation dynamics are different from country to country in
Asia. China is now in deflation whilst some of the
South East Asian countries have seen a moderate rise in inflation
(albeit lower than that observed in Europe or the US). This has led to higher
interest rates and weakening consumption as governments have
behaved responsibly and not expanded fiscal spending (unlike the
US).
We believe, therefore, that while there has been some consumer
price inflation in Asia, it is not
as big an issue as it is in the West.
Question
Can you give an example of how your active management has
added value to the Company’s portfolio this
year?
Answer
As discussed earlier, our process is focused on finding
misunderstood situations where we can own a good business with a
margin of safety. Shriram Finance is a good example of this. It has
become the largest retail non-banking financial company (NBFC) in
India caused by the merger of
Shriram Transport Finance Company, the largest financier of used
commercial vehicles, and Shriram City Union Finance, the largest
financier of two-wheelers and the underserved micro, small, and
medium enterprises (MSME).
We have owned Shriram Transport Finance Company since late 2016
when we bought it at an attractive valuation when Indian
non-banking financials saw short-term pressures due to tight
liquidity. Over several decades, the company created its niche in a
segment where banks did not compete due to difficulty in valuing
and underwriting loans for second-hand trucks. It owned a quarter
of the market share in the segment while the rest of the market was
dominated by local money lenders, outside of the banking system,
charging very high interest rates. We also owned Shriram City Union
Finance for its strong track record in segments that have
semi-formal and irregular sources of income and hence were credit
starved.
The merger last year has created a lender with a more diversified
book while also bringing benefits from synergies between the two
businesses. The stock rerated as a result.
Question
Can you explain to us how you integrate ESG considerations
into the Company’s portfolio?
Answer
The Company’s primary objective for shareholders is to achieve
capital growth. In order to achieve the best possible returns, we
have always looked to invest in good businesses, managed by
efficient management teams and available at reasonable valuations.
Good businesses are those that solve a problem for their consumers,
and which are managed by efficient teams who are competent and
which respect laws, their employees, customers, the environment and
shareholders, as well as managing their businesses responsibly. ESG
considerations have, therefore, always been at the heart of our
investment thinking, and well before it became a buzz
word.
Investing in smaller companies in Asia using the strength of Fidelity’s research
team has always offered us the opportunity to identify quality
companies on fundamentals and ESG considerations ahead of other
investors. Regulations are constantly evolving and ESG is no
exception to this. We believe this presents us with opportunities.
The development of ESG ratings covered by the external rating
agencies has not yet evolved to cover many of the smaller companies
in which we invest. This provides an exciting opportunity as the
ESG credentials of many of the smaller companies are best in class.
They are in fact ‘double gems’: companies with good prospects,
strong management and well-priced alongside their strong ESG
credentials.
Additionally, Fidelity as a firm is committed to principles that
are consistent with the stage of economic development of countries.
As part of this process, we have regular engagements with companies
in the portfolio.
Examples of our ESG case studies are in the Annual
Report.
Question
What do you view as the biggest risks and opportunities for
the next twelve months?
Answer
We think macro risks will eventually pass, especially if we own a
diversified set of leading businesses and own them at valuations
which are below intrinsic value. However, this does not mean that
these stocks cannot decline in value – to the contrary, forecasting
price movements is impossible. But we believe that the quality of
our portfolio gives us holding power to go through head winds as
they emerge and come out stronger on the other side.
As can be seen from the chart in the Annual Report, the ROE of our
portfolio is at a premium to the market while the Price to Earnings
ratio of our holdings is at a significant discount. We own
businesses which are of a better quality and at cheaper market
valuations. This has been the bedrock of our investment process for
over a decade and has served us well.
Our skills lie in business analysis, finding best in class
management teams and mispriced stocks. We are known to repeat the
phrase below often and it is fair to say that it has become known
as something of a mantra for the Company:
Find good businesses run by good management and buy them at
prices with a good margin of safety.
We continue to focus on this.
NITIN
BAJAJ AJINKYA
DHAVALE
Portfolio Manager Assistant
Portfolio Manager
11 October 2023
PRINCIPAL RISKS AND UNCERTAINTIES AND RISK
MANAGEMENT
As required by provisions 28 and 29 of the 2018 UK Corporate
Governance Code, the Board has a robust ongoing process for
identifying, evaluating and managing the principal risks and
uncertainties faced by the Company, including those that could
threaten its business model, future performance, solvency and
liquidity. The Board, with the assistance of the Alternative
Investment Fund Manager (FIL Investment Services (UK) Limited/ the
“Manager”), has developed a risk matrix which, as part of the risk
management and internal controls process, identifies the key
existing and emerging risks and uncertainties that the Company
faces. The Audit Committee continues to identify any new emerging
risks and take any action necessary to mitigate their potential
impact. The risks identified are placed on the Company’s risk
matrix and appropriately graded. This process, together with the
policies and procedures for the mitigation of existing and emerging
risks, is updated and reviewed regularly in the form of
comprehensive reports by the Audit Committee. The Board determines
the nature and extent of any risks it is willing to take in order
to achieve its strategic objectives.
Climate change, which refers to a large scale shift in the planet’s
weather patterns and average temperatures, continues to be a key
emerging issue as well as a principal risk confronting asset
managers and their investors. The Board notes that the Manager has
integrated ESG considerations, including climate change, into the
Company’s investment process. Further details are in the Annual
Report. The Board will continue to monitor how this may impact the
Company as a risk to investment valuations and potentially to
shareholder returns.
The Manager also has responsibility for risk management for the
Company. It works with the Board to identify and manage the
principal and emerging risks and uncertainties and to ensure that
the Board can continue to meet its UK corporate governance
obligations.
The Board considers the risks listed below as the principal risks
and uncertainties faced by the Company.
Principal Risks
|
Description and Risk Mitigation
|
Economic, Political and Market Risks
|
The Company and its assets may be affected by economic and market
risks. These are market downturns, interest rate movements,
deflation/inflation, exchange rate movements and market shocks,
such as the post pandemic economic recovery and volatility from the
war in Ukraine. Inflation remains elevated across most economies
driven by a combination of increased demand following pandemic
restrictions being lifted, global labour shortages in some sectors
and supply chain shortages, including energy and food
security.
The Company is exposed to a number of geopolitical risks. The
fast-changing global geopolitical landscape is largely shaped by
the Russia and Ukraine war effects, deglobalisation trends and
significant supply disruption, as well as fears of global recession
amid inflationary pressures and financial distress. Russia and
Ukraine are both significant net exporters of oil, natural gas and
a variety of soft commodities and supply limitations fuelled global
inflation and economic instability, specifically within Western
nations. Whilst the direct impact of the war to APAC markets has
been less severe than European counterparts, the prolonged
cost-of-living crisis risks continue to impact Western investment
appetite. China’s economy remains vulnerable to risks related to
the global outlook and geopolitical tensions including US-China
trade war, South China sea dispute and implications of China-Taiwan
relations.
Most of the Company’s assets and income are denominated in
currencies other than sterling which is the Company’s functional
and presentation currency. As a result, movements in exchange rates
may affect the sterling value of its assets and income.
The Company’s portfolio is made up mainly of listed securities. The
Portfolio Manager’s success or failure to protect and increase the
Company’s assets against the above background is core to the
Company’s continued success. His investment philosophy of
stock-picking and investing in attractively valued companies aims
to outperform the Comparative Index over time.
The Board is provided with a detailed investment review which
covers material economic, political and market risks and
legislative changes at each Board meeting.
Risks to which the Company is exposed to in the market and currency
risk category are included in Note 17 to the Financial Statements
below together with summaries of the policies for managing these
risks.
|
Investment Performance Risk (including the use of
Derivatives and Gearing)
|
The achievement of the Company’s investment performance objective
relative to the market requires the taking of risk, such as
investment strategy, asset allocation and stock selection, and may
lead to NAV and share price underperformance compared to the
Comparative Index and/or peer group companies. Continued
underperformance could lead to the Company and its objective
becoming unattractive to investors. The Investment Manager is
responsible for actively monitoring the portfolio selected in
accordance with the asset allocation parameters and seeks to ensure
that individual stocks meet an acceptable risk/reward
profile.
In order to manage this risk, the Board reviews Fidelity’s
compliance with agreed investment restrictions; investment
performance and risk; relative performance; the portfolio’s risk
profile; and whether appropriate strategies are employed to
mitigate any negative impact of substantial changes in the markets.
The Board also regularly canvasses major shareholders for their
views with respect to company matters.
Derivative instruments are used to protect and enhance investment
returns. There is a risk that the use of derivatives may lead to
higher volatility in the NAV and the share price than might
otherwise be the case. The Board has put in place policies and
limits to control the Company’s use of derivatives and exposures.
These are monitored on a daily basis by the Manager’s Compliance
team and regular reports are provided to the Board. Further detail
on derivative instruments risk is included in Note 17 to the
Financial Statements below.
The Company gears through the use of long CFDs which provide
greater flexibility and are generally cheaper than bank loans. The
principal risk is that the Portfolio Manager fails to use gearing
effectively, resulting in a failure to outperform in a rising
market or to underperform in a falling market. The Board regularly
considers the level of gearing and gearing risk and sets limits
within which the Manager must operate.
|
Cybercrime and Information Security
Risks
|
The operational risk from cybercrime is significant. Cybercrime
threats evolve rapidly and consequently the risk is regularly
re-assessed and the Board receives regular updates from the Manager
in respect of the type and possible scale of cyberattacks. The
Manager’s technology team has developed a number of initiatives and
controls in order to provide enhanced mitigating protection to this
ever-increasing threat. The risk is frequently re-assessed by
Fidelity’s information security teams and has resulted in the
implementation of new tools and processes, as well as improvements
to existing ones. Fidelity has a dedicated cybersecurity team which
provides regular awareness updates and best practice
guidance.
Risks are increased due to the Russia/Ukraine conflict and the
trend to more working from home following the pandemic. These
primarily relate to phishing, remote access threats, extortion and
denial of services attacks. The Manager has dedicated detect and
respond resources specifically to monitor the cyber threats
associated within the workplace and increased cyber activity
following Russia’s invasion of Ukraine. There are a number of
mitigating actions in place including, control strengthening,
geo-blocking and phishing mitigants, combined with enhanced
resilience and recovery options.
The Company’s third-party service providers also have similar
measures in place.
|
Level of Discount to the Net Asset
Value
|
Due to the nature of investment companies, the price of the
Company’s shares and its discount to NAV are factors which are not
totally within the Company’s control. The Board has a discount
management policy in place and some short-term influence over the
discount may be exercised by the use of share repurchases at
acceptable prices and within the parameters set by the Board. In
considering the risk that the discount to NAV poses to shareholder
value and returns, both the absolute level of the discount and the
amount relative to the Company’s peer group and the wider market
are considered. The Company’s share price, NAV and discount
volatility are monitored daily by the Manager and the Company’s
Broker and considered by the Board on a regular basis. The demand
for shares can be influenced through good performance and an active
investor relations programme.
|
Key Person Risk
|
The Portfolio Manager, Nitin Bajaj, has a differentiated style in
relation to his peers. This style is intrinsically linked with the
Company’s investment philosophy and strategy and, therefore, the
Company has a key person dependency on him. The Company has an
Assistant Portfolio Manager, Ajinka Dhavale, who supports the
Portfolio Manager, and has extensive experience in the Asian
markets and companies and shares a common investment approach and
complementary investment experience with the Portfolio Manager. The
Portfolio Manager is also supported by an Investment Director,
Catherine Yeung, as a primary spokesperson for the Company. This
helps strengthen the investment process.
There is also a risk that the Manager has inadequate succession
plans for other key operational individuals. The Manager identifies
key dependencies which are then addressed through succession plans,
particularly for portfolio managers.
|
Environmental, Social and Governance (“ESG”)
Risks
|
There is a risk that the value of the assets of the Company are
negatively impacted by ESG related risks, including climate change
risk. ESG risks include investor expectations and how the Company
is positioned from a marketing perspective and whether it is
compliant with its ESG disclosure requirements. Fidelity has
embedded ESG factors in its investment decision- making process.
ESG integration is carried out at the fundamental research analyst
level within its investment teams, primarily through Fidelity’s
Proprietary Sustainability Rating which is designed to generate a
forward-looking and holistic assessment of a company’s ESG risks
and opportunities based on sector-specific key performance
indicators across 127 individual and unique sub-sectors. The
Portfolio Manager is also active in analysing the effects of ESG
when making investment decisions. The Board continues to monitor
developments in this area and reviews the positioning of the
portfolio considering ESG factors.
ESG ratings and carbon emissions of the companies within the
Company’s portfolio compared to the Index are provided in the
Annual Report. Further detail on ESG considerations in the
investment process and sustainable investing is set out in the
Annual Report.
|
Business Continuity and Operational
Risks
|
There continues to be increased focus from financial services
regulators around the world on the contingency plans of regulated
financial firms. The top risks globally are cybersecurity and
geopolitical events. There are also ongoing risks following
Russia’s invasion into Ukraine, specifically regarding the
potential loss of power and/or broadband services. Variants of
COVID continue to evolve and some risks remain.
The Manager continues to take all reasonable steps to meet its
regulatory obligations, assess its ability to continue operating
and the steps it needs to take to support its clients, including
the Board and has an appropriate control environment in place. The
Manager has provided the Board with assurance that the Company has
appropriate business continuity plans and the provision of services
has continued to be supplied without interruption.
Specific risks posed by the pandemic continue to ease with
increasing levels of staff returning to routine office-based
working, albeit under hybrid working arrangements which allows
greater flexibility on remote working as part of the new operating
model.
The Company relies on a number of third-party service providers,
principally the Registrar, Custodian and Depositary. They are all
subject to a risk-based programme of internal audits by the Manager
and their own internal controls reports are received by the Manager
on behalf of the Board on an annual basis and any concerns are
investigated. The third-party service providers have also confirmed
the implementation of appropriate measures to ensure no business
disruption.
Risks associated with these services are generally rated as low,
but the financial consequences could be serious, including
reputational damage to the Company.
|
Shareholder Relationships
|
There is a risk that the Board has insufficient access to
shareholders or that the Portfolio
Manager’s investment style is not appealing for investors. There is
also a risk that continued weak investment performance may
potentially make the Company less attractive to retail and wealth
managers.
The shareholder register and shareholder activity are reviewed at
each Board meeting and regular shareholder meetings are organised
by the Broker with the Board and Fidelity, including the Portfolio
Manager and Investment Director. Fidelity has an investment
companies’ website which has dedicated pages for the Company and
regular updates are provided for investors.
|
Other risks facing the Company include:
TAX AND REGULATORY RISKS
There is a risk of the Company not complying with tax and
regulatory requirements. A breach of Section 1158 of the
Corporation Tax Act 2010 could lead to a loss of investment trust
status resulting in the Company being subject to tax on capital
gains.
The Board monitors tax and regulatory changes at each Board meeting
and through active engagement by the Manager with regulators and
trade bodies.
The Company has a full risk register which includes less material
risks which the Board reviews at least annually.
GOING CONCERN STATEMENT
The Directors have considered the Company’s investment objective,
risk management policies, liquidity risk, credit risk, capital
management policies and procedures, the nature of its portfolio and
its expenditure and cash flow projections. The Directors, having
considered the liquidity of the Company’s portfolio of investments
(being mainly securities which are readily realisable) and the
projected income and expenditure, are satisfied that the Company is
financially sound and has adequate resources to meet all of its
liabilities and ongoing expenses and continue in operational
existence for the foreseeable future. The Board has, therefore,
concluded that the Company has adequate resources to continue to
adopt the going concern basis for the period to 31 October 2024 which is at least twelve months
from the date of approval of the Financial Statements. This
conclusion also takes into account the Board’s assessment of the
ongoing risks from the war in Ukraine, China’s tensions with the US and
Taiwan and significant market
events.
Accordingly, the Financial Statements of the Company have been
prepared on a going concern basis.
The prospects of the Company over a period longer than twelve
months can be found in the Viability Statement below.
VIABILITY STATEMENT
In accordance with provision 31 of the 2018 UK Corporate Governance
Code, the Directors have assessed the prospects of the Company over
a longer period than the twelve month period required by the “Going
Concern” basis above. The Company is an investment trust with the
objective of achieving long-term capital growth. The Board
considers long-term to be at least five years, and accordingly, the
Directors believe that five years is an appropriate investment
horizon to assess the viability of the Company, although the life
of the Company is not intended to be limited to this or any other
period.
In making an assessment on the viability of the Company, the Board
has considered the following:
- The
ongoing relevance of the investment objective in prevailing market
conditions;
- The
Company’s level of gearing;
- The
Company’s NAV and share price performance versus its Comparative
Index;
- The
principal and emerging risks and uncertainties facing the Company
and their potential impact as set out above;
- The
future demand for the Company’s shares;
- The
Company’s share price discount to the NAV;
- The
liquidity of the Company’s portfolio;
- The
level of income generated by the Company; and
- Future
income and expenditure forecasts.
The Company’s performance for the five year reporting period to
31 July 2023 lagged the Comparative
Index, with a NAV total return of +45.4%, a share price total
return of +41.1% compared to the Comparative Index total return of
+50.7%. The Board regularly reviews the investment policy and
considers it remains appropriate. The Board has concluded that
there is a reasonable expectation that the Company will be able to
continue in operation and meet its liabilities as they fall due
over the next five years based on the following
considerations:
- The
Investment Manager’s compliance with the Company’s investment
objective and policy, its investment strategy and asset
allocation;
- The
Company’s portfolio mainly comprises readily realisable securities
which can be sold to meet funding requirements if
necessary;
- The
Board’s discount management policy; and
- The
ongoing processes for monitoring operating costs and income which
are considered to be reasonable in comparison to the Company’s
total assets.
In preparing the Financial Statements, the Directors have
considered the impact of climate change, as detailed above. The
Board has also considered the impact of regulatory changes,
continuing tensions between the US and China, tensions with Taiwan and the ongoing global implications of
the Ukraine and Russia war, and how this may affect the
Company.
In addition, the Directors’ assessment of the Company’s ability to
operate in the foreseeable future is included in the Going Concern
Statement above.
A continuation vote takes place every five years. There is a risk
that shareholders do not vote in favour of the continuation of the
Company during periods when performance of the Company’s NAV and
share price is poor. The last continuation vote was at the
Company’s AGM held on 3 December
2021. The next continuation vote will take place at the AGM
in 2026.
PROMOTING THE SUCCESS OF THE COMPANY
Under Section 172(1) of the Companies Act 2006, the Directors of a
company must act in a way they consider, in good faith, would be
most likely to promote the success of the Company for the benefit
of its members as a whole, and in doing so have regard (amongst
other matters) to the likely consequences of any decision in the
long-term; the need to foster relationships with the Company’s
suppliers, customers and others; the impact of the Company’s
operations on the community and the environment; the desirability
of the Company maintaining a reputation for high standards of
business conduct; and the need to act fairly as between members of
the Company.
As an externally managed Investment Trust, the Company has no
employees or physical assets, and a number of the Company’s
functions are outsourced to third parties. The key outsourced
function is the provision of investment management services by the
Manager, but other professional service providers support the
Company by providing administration, custodial, banking and audit
services. The Board considers the Company’s key stakeholders to be
the existing and potential shareholders, the external appointed
Manager and other third-party professional service providers. The
Board considers that the interest of these stakeholders is aligned
with the Company’s objective of delivering long-term capital growth
to investors, in line with the Company’s stated investment
objective and strategy, while providing the highest standards of
legal, regulatory and commercial conduct.
The Board, with the Portfolio Manager, sets the overall investment
strategy and reviews this at an annual strategy day which is
separate from the regular cycle of board meetings. In order to
ensure good governance of the Company, the Board has set various
limits on the investments in the portfolio, whether in the maximum
size of individual holdings, the use of derivatives, the level of
gearing and others. These limits and guidelines are regularly
monitored and reviewed and are set out in the Annual
Report.
The Board places great importance on communication with
shareholders. The Annual General Meeting (“AGM”) provides the key
forum for the Board and the Portfolio Manager to present to the
shareholders on the Company’s performance and future plans and the
Board encourages all shareholders to attend either in person or
virtually and raise any questions or concerns. The Chairman and
other Board members are available to meet shareholders as
appropriate. Shareholders may also communicate with Board members
at any time by writing to them at the Company’s registered office
at FIL Investments International, Beech Gate, Millfield Lane, Tadworth, Surrey KT20 6RP
or via the Company Secretary in writing at the same address or by
email at
investmenttrusts@fil.com.
The Portfolio Manager meets with major shareholders, potential
investors, stock market analysts, journalists and other
commentators during the year. These communication opportunities
help inform the Board in considering how best to promote the
success of the company over the long-term.
The Board seeks to engage with the Manager and other service
providers and advisers in a constructive and collaborative way,
promoting a culture of strong governance, while encouraging open
and constructive debate, in order to ensure appropriate and regular
challenge and evaluation. This aims to enhance service levels and
strengthen relationships with service providers, with a view to
ensuring shareholders’ interests are best served, by maintaining
the highest standards of commercial conduct while keeping cost
levels competitive.
Whilst the Company’s direct operations are limited, the Board
recognises the importance of considering the impact of the
Company’s investment strategy on the wider community and
environment. The Board believes that a proper consideration of ESG
issues aligns with the investment objective to deliver long-term
capital growth, and the Board’s review of the Manager includes an
assessment of their ESG approach, which is set out in detail in the
Annual Report.
In addition to ensuring that the Company’s investment objective was
being pursued, key decisions and actions taken by the Directors
during the reporting year, and up to the date of this report, have
included:
- As
part of the Board’s succession plans:
– The
appointment of Hussein Barma to the
Board as Chairman of the Audit Committee and non-executive Director
with effect from 24 November
2022;
– The
decision to appoint Clare Brady as
Chairman of the Board when the current Chairman, Kate Bolsover, steps down at the conclusion of
the AGM on 29 November 2023;
and
– The
decision to appoint Matthew
Sutherland as Senior Independent Director with effect from
29 November 2023 from the change in
Clare Brady’s role from Senior Independent Director to
Chairman.
- Authorising
the repurchase of 569,000 ordinary shares up to the date of this
Annual Report when the Company’s discount widened, in line with the
Board’s discount management policy;
- The
decision to recommend the payment of a final dividend of
14.50 pence per ordinary share;
and
- The
decision to once again hold a hybrid AGM in 2023 in order to make
it more accessible to those investors who are unable to or prefer
not to attend in person.
STATEMENT
OF DIRECTORS’ RESPONSIBILITIES
The Directors are responsible for preparing the Annual Report and
Financial Statements in accordance with applicable law and
regulations.
Company law requires the Directors to prepare Financial Statements
for each financial period. Under that law they have elected to
prepare the Financial Statements in accordance with UK Generally
Accepted Accounting Practice (UK Accounting Standards and
applicable law), including Financial Reporting Standard FRS 102:
The Financial Reporting Standard applicable in the UK and
Republic of Ireland (“FRS 102”).
Under company law, the Directors must not approve the Financial
Statements unless they are satisfied that they give a true and fair
view of the state of affairs of the Company and of the profit or
loss for the reporting period.
In preparing these Financial Statements, the Directors are required
to:
- Select
suitable accounting policies in accordance with Section 10 of FRS
102 and then apply them consistently;
- Make
judgements and accounting estimates that are reasonable and
prudent;
- Present
information, including accounting policies, in a manner that
provides relevant, reliable, comparable and understandable
information;
- State
whether applicable UK Accounting Standards, including FRS 102, have
been followed, subject to any material departures disclosed and
explained in the Financial Statements; and
- Prepare
the Financial Statements on the going concern basis unless it is
inappropriate to presume that the Company will continue in
business.
The Directors are responsible for keeping adequate accounting
records that are sufficient to show and explain the Company’s
transactions and disclose with reasonable accuracy at any time, the
financial position of the Company and to enable them to ensure that
the Company and the Financial Statements comply with the Companies
Act 2006. They are also responsible for safeguarding the assets of
the Company and hence for taking reasonable steps for the
prevention and detection of fraud and other
irregularities.
Under applicable law and regulations, the Directors are also
responsible for preparing a Strategic Report, a Directors’ Report,
a Corporate Governance Statement and a Directors’ Remuneration
Report that comply with that law and those regulations.
The Directors have delegated to the Manager the responsibility for
the maintenance and integrity of the corporate and financial
information included on the Company’s pages of the Manager’s
website at
www.fidelity.co.uk/asianvalues.
Visitors to the website need to be aware that legislation in the UK
governing the preparation and dissemination of the Financial
Statements may differ from legislation in their own
jurisdictions.
The Directors confirm that to the best of their
knowledge:
- The
Financial Statements, prepared in accordance with UK Generally
Accepted Accounting Practice, including FRS 102, give a true and
fair view of the assets, liabilities, financial position and profit
of the Company;
- The
Annual Report, including the Strategic Report, includes a fair
review of the development and performance of the business and the
position of the Company, together with a description of the
principal risks and uncertainties it faces; and
- The
Annual Report and Financial Statements, taken as a whole, are fair,
balanced and understandable and provide the information necessary
for shareholders to assess the Company’s performance, business
model and strategy.
The Statement of Directors’ Responsibilities was approved by the
Board on 11 October 2023 and signed
on its behalf by:
KATE
BOLSOVER
Chairman
FINANCIAL
STATEMENTS
Income Statement for the year ended 31 July 2023
|
|
Year ended 31 July 2023
|
Year ended 31 July 2022
|
|
Notes
|
Revenue
£’000
|
Capital
£’000
|
Total
£’000
|
Revenue
£’000
|
Capital
£’000
|
Total
£’000
|
Gains on investments
|
10
|
–
|
29,025
|
29,025
|
–
|
2,708
|
2,708
|
Gains/(losses) on derivative instruments
|
11
|
–
|
1,781
|
1,781
|
–
|
(1,815)
|
(1,815)
|
Income
|
3
|
17,773
|
–
|
17,773
|
15,256
|
–
|
15,256
|
Investment management fees
|
4
|
(2,644)
|
(281)
|
(2,925)
|
(2,564)
|
732
|
(1,832)
|
Other expenses
|
5
|
(988)
|
–
|
(988)
|
(905)
|
–
|
(905)
|
Foreign exchange gains
|
|
–
|
1,089
|
1,089
|
–
|
2,609
|
2,609
|
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
Net return on ordinary activities before finance costs and
taxation
|
|
14,141
|
31,614
|
45,755
|
11,787
|
4,234
|
16,021
|
Finance costs
|
6
|
(1,997)
|
–
|
(1,997)
|
(331)
|
–
|
(331)
|
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
Net return on ordinary activities before
taxation
|
|
12,144
|
31,614
|
43,758
|
11,456
|
4,234
|
15,690
|
Taxation on return on ordinary activities
|
7
|
(1,238)
|
(2,882)
|
(4,120)
|
(1,079)
|
(1,085)
|
(2,164)
|
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
Net return on ordinary activities after taxation for the
year
|
|
10,906
|
28,732
|
39,638
|
10,377
|
3,149
|
13,526
|
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
Return per ordinary share
|
8
|
15.17p
|
39.95p
|
55.12p
|
14.21p
|
4.31p
|
18.52p
|
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
The Company does not have any other comprehensive income.
Accordingly, the net return on ordinary activities after taxation
for the year is also the total comprehensive income for the year
and no separate Statement of Comprehensive Income has been
presented.
The total column of this statement represents the Income Statement
of the Company. The revenue and capital columns are supplementary
and presented for information purposes as recommended by the
Statement of Recommended Practice issued by the AIC.
No operations were acquired or discontinued in the year and all
items in the above statement derive from continuing
operations.
The Notes below form an integral part of these Financial
Statements.
Statement of Changes in Equity for the year ended
31 July 2023
|
Notes
|
Share
capital
£’000
|
Share
premium
account
£’000
|
Capital
redemption
reserve
£’000
|
Other non-
distributable
reserve
£’000
|
Other
reserve
£’000
|
Capital
reserve
£’000
|
Revenue
reserve
£’000
|
Total
shareholders’
funds
£’000
|
Total shareholders’ funds at 31 July
2022
|
|
18,895
|
50,501
|
3,197
|
7,367
|
–
|
273,448
|
14,215
|
367,623
|
Net return on ordinary activities after taxation for the
year
|
|
–
|
–
|
–
|
–
|
–
|
28,732
|
10,906
|
39,638
|
Repurchase of ordinary shares
|
14
|
–
|
–
|
–
|
–
|
–
|
(2,618)
|
–
|
(2,618)
|
Dividend paid to shareholders
|
9
|
–
|
–
|
–
|
–
|
–
|
–
|
(10,066)
|
(10,066)
|
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
Total shareholders’ funds at 31 July
2023
|
|
18,895
|
50,501
|
3,197
|
7,367
|
–
|
299,562
|
15,055
|
394,577
|
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
Total shareholders’ funds at 31 July
2021
|
|
18,895
|
50,501
|
3,197
|
7,367
|
719
|
273,107
|
10,278
|
364,064
|
Net return on ordinary activities after taxation for the
year
|
|
–
|
–
|
–
|
–
|
–
|
3,149
|
10,377
|
13,526
|
Repurchase of ordinary shares
|
14
|
–
|
–
|
–
|
–
|
(719)
|
(2,808)
|
–
|
(3,527)
|
Dividend paid to shareholders
|
9
|
–
|
–
|
–
|
–
|
–
|
–
|
(6,440)
|
(6,440)
|
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
Total shareholders’ funds at 31 July
2022
|
|
18,895
|
50,501
|
3,197
|
7,367
|
–
|
273,448
|
14,215
|
367,623
|
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
The Notes below form an integral part of these Financial
Statements.
Balance
Sheet as at 31 July
2023
Company number 3183919
|
Notes
|
2023
£’000
|
2022
£’000
|
Fixed assets
|
|
|
|
Investments
|
10
|
377,631
|
338,845
|
|
|
---------------
|
---------------
|
Current assets
|
|
|
|
Derivative instruments
|
11
|
1,758
|
972
|
Debtors
|
12
|
3,556
|
4,568
|
Amounts held at futures clearing houses and brokers
|
|
3,820
|
2,997
|
Cash at bank
|
|
13,029
|
25,368
|
|
|
---------------
|
---------------
|
|
|
22,163
|
33,905
|
|
|
=========
|
=========
|
Current liabilities
|
|
|
|
Derivative instruments
|
11
|
(1,665)
|
(1,302)
|
Other creditors
|
13
|
(3,552)
|
(3,825)
|
|
|
---------------
|
---------------
|
|
|
(5,217)
|
(5,127)
|
|
|
=========
|
=========
|
Net current assets
|
|
16,946
|
28,778
|
|
|
=========
|
=========
|
Net assets
|
|
394,577
|
367,623
|
|
|
=========
|
=========
|
Capital and reserves
|
|
|
|
Share capital
|
14
|
18,895
|
18,895
|
Share premium account
|
15
|
50,501
|
50,501
|
Capital redemption reserve
|
15
|
3,197
|
3,197
|
Other non-distributable reserve
|
15
|
7,367
|
7,367
|
Other reserve
|
15
|
–
|
–
|
Capital reserve
|
15
|
299,562
|
273,448
|
Revenue reserve
|
15
|
15,055
|
14,215
|
|
|
---------------
|
---------------
|
Total shareholders’ funds
|
|
394,577
|
367,623
|
|
|
=========
|
=========
|
Net asset value per ordinary share
|
16
|
549.33p
|
507.78p
|
|
|
=========
|
=========
|
The Financial Statements above and below were approved by the Board
of Directors on 11 October 2023 and
were signed on its behalf by:
KATE
BOLSOVER
Chairman
The Notes below form an integral part of these Financial
Statements.
Notes
to the Financial Statements
1
Principal Activity
Fidelity Asian Values PLC is an Investment Company incorporated in
England and Wales with a premium listing on the London
Stock Exchange. The Company’s registration number is 3183919, and
its registered office is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth,
Surrey KT20 6RP. The Company has been approved by HM Revenue
& Customs as an Investment Trust under Section 1158 of the
Corporation Tax Act 2010 and intends to conduct its affairs so as
to continue to be approved.
2
Accounting Policies
The Company has prepared its Financial Statements in accordance
with UK Generally Accepted Accounting Practice (“UK GAAP”),
including FRS 102 “The Financial Reporting Standard applicable in
the UK and Republic of Ireland”, issued by the Financial Reporting
Council (“FRC”). The Financial Statements have also been prepared
in accordance with the Statement of Recommended Practice: Financial
Statements of Investment Trust Companies and Venture Capital Trusts
(“SORP”) issued by the Association of Investment Companies (“AIC”),
in July 2022. The Company is exempt
from presenting a Cash Flow Statement as a Statement of Changes in
Equity is presented and substantially all of the Company’s
investments are highly liquid and are carried at market
value.
a) Basis of accounting
– The Financial Statements have been prepared on a going concern
basis and under the historical cost
convention, except for the measurement at fair value of investments
and derivative instruments. The Directors have a reasonable
expectation that the Company has adequate resources to continue in
operational existence up to 31 October
2024 which is at least twelve months from the date of
approval of these Financial Statements. In making their assessment
the Directors have reviewed income and expense projections,
reviewed the liquidity of the investment portfolio and considered
the Company’s ability to meet liabilities as they fall due. This
conclusion also takes into account the Director’s assessment of the
risks faced by the Company as detailed in the Going Concern
Statement above.
In preparing these Financial Statements the Directors have
considered the impact of climate change risk as a principal and an
emerging risk as set out above, and have concluded that there was
no further impact of climate change to be taken into account as the
investments are valued based on market pricing. In line with FRS
102 investments are valued at fair value, which for the Company are
quoted bid prices for investments in active markets at the balance
sheet date. Investments which are unlisted are priced using
market-based valuation approaches. All investments, therefore,
reflect the market participants’ view of climate change risk on the
investments held by the Company.
The Company’s Going Concern Statement above takes account of all
events and conditions up to 31 October
2024 which is at least twelve months from the date of
approval of these Financial Statements.
b) Significant accounting estimates and
judgements
– The preparation of the Financial Statements requires the use of
estimates
and judgements. These estimates and judgements affect the reported
amounts of assets and liabilities at the reporting date. While
estimates are based on best judgement using information and
financial data available, the actual outcome may differ from these
estimates.
The key sources of estimation and uncertainty relate to the fair
value of the unlisted investments.
Judgements
The Directors consider whether each fair value is appropriate
following detailed review and challenge of the pricing methodology.
The judgement applied in the selection of the methodology used (see
Note 2 (k) below) for determining the fair value of each unlisted
investment can have a significant impact upon the
valuation.
Estimates
The key estimate in the Financial Statements is the determination
of the fair value of the unlisted investments by the Manager’s Fair
Value Committee (“FVC”), with support from an external valuer and
Fidelity’s unlisted investments specialist, for detailed review and
appropriate challenge by the Directors. This estimate is key as it
significantly impacts the valuation of the unlisted investments at
the Balance Sheet date. When no recent primary or secondary
transaction in the company’s shares have taken place, the fair
valuation process involves estimation using subjective inputs that
are unobservable (for which market data is unavailable). The
estimates involved in the valuation process may include the
following:
(i) the
selection of appropriate comparable companies. Comparable companies
are chosen on the basis of their business characteristics and
growth patterns;
(ii) the
selection of a revenue metric (either historical or
forecast);
(iii) the
selection of an appropriate illiquidity discount factor to reflect
the reduced liquidity of unlisted companies versus their listed
peers;
(iv) the
estimation of the likelihood of a future exit of the position
through an initial public offering (“IPO”) or a company
sale;
(v) the
selection of an appropriate industry benchmark index to assist with
the valuation; and
(vi) the
calculation of valuation adjustments derived from milestone
analysis and future cash flows (i.e. incorporating operational
success against the plans/forecasts of the business into the
valuation).
As the valuation outcomes may differ from the fair value estimates
a price sensitivity analysis is provided in Other Price Risk
Sensitivity in Note 17 below to illustrate the effect on the
Financial Statements of an over or under estimation of fair
value.
The risk of an over or under estimation of fair value is greater
when methodologies are applied using more subjective
inputs.
c) Segmental reporting
– The Company is engaged in a single segment business and,
therefore, no segmental reporting is
provided.
d) Presentation of the Income Statement
– In order to reflect better the activities of an investment
company and in accordance
with guidance issued by the AIC, supplementary information which
analyses the Income Statement between items of a revenue and
capital nature has been prepared alongside the Income Statement.
The net revenue return after taxation for the year is the measure
the Directors believe appropriate in assessing the Company’s
compliance with certain requirements set out in Section 1159 of the
Corporation Tax Act 2010.
e) Income
– Income from equity investments is accounted for on the date on
which the right to receive the payment is established,
normally the ex-dividend date. Overseas dividends are accounted for
gross of any tax deducted at source. Amounts are credited to the
revenue column of the Income Statement. Where the Company has
elected to receive its dividends in the form of additional shares
rather than cash, the amount of the cash dividend foregone is
recognised in the revenue column of the Income Statement. Any
excess in the value of the shares received over the amount of the
cash dividend is recognised in the capital column of the Income
Statement. Special dividends are treated as a revenue receipt or a
capital receipt depending on the facts and circumstances of each
particular case.
Derivative instrument income received from dividends on long
contracts for difference (“CFDs”) are accounted for on the date on
which the right to receive the payment is established, normally the
ex-dividend date. The amount net of tax is credited to the revenue
column of the Income Statement.
Interest received on CFDs, collateral and bank deposits are
accounted for on an accruals basis and credited to the revenue
column of the Income Statement. Interest received on CFDs represent
the finance costs calculated by reference to the notional value of
the CFDs.
f) Investment management fees and other
expenses
– Investment management fees and other expenses are accounted for
on an
accruals basis and are charged as follows:
- The
base investment management fee is allocated in full to
revenue;
- The
variable investment management fee, is charged/credited to capital
as it is based on the performance of the net asset value per share
relative to the Benchmark Index; and
- All
other expenses are allocated in full to revenue with the exception
of those directly attributable to share issues or other capital
events.
g) Functional currency and foreign exchange
– The functional and reporting currency of the Company is UK
sterling, which is the
currency of the primary economic environment in which the Company
operates. Transactions denominated in foreign currencies are
reported in UK sterling at the rate of exchange ruling at the date
of the transaction. Assets and liabilities in foreign currencies
are translated in the rates of exchange ruling at the Balance Sheet
date. Foreign exchange gains and losses arising on the translation
are recognised in the Income Statement as a revenue or a capital
item depending on the nature of the underlying item to which they
relate.
h) Finance costs
– Finance costs comprise interest on bank overdrafts and collateral
and finance costs paid on CFDs, which are
accounted for on an accruals basis, and dividends paid on short
CFDs, which are accounted for on the date on which the obligation
to incur the cost is established, normally the ex-dividend date.
Finance costs are charged in full to the revenue column of the
Income Statement.
i) Taxation
– The taxation charge represents the sum of current taxation and
deferred taxation.
Current taxation is taxation suffered at source on overseas income
less amounts recoverable under taxation treaties. Taxation is
charged or credited to the revenue column of the Income Statement,
except where it relates to items of a capital nature, in which case
it is charged or credited to the capital column of the Income
Statement. Where expenses are allocated between revenue and capital
any tax relief in respect of the expenses is allocated between
revenue and capital returns on the marginal basis using the
Company’s effective rate of corporation tax for the accounting
period. The Company is an approved Investment Trust under Section
1158 of the Corporation Tax Act 2010 and is not liable for UK
taxation on capital gains.
Deferred taxation is the taxation expected to be payable or
recoverable on timing differences between the treatment of certain
items for accounting purposes and their treatment for the purposes
of computing taxable profits. Deferred taxation is based on tax
rates that have been enacted or substantively enacted when the
taxation is expected to be payable or recoverable. Deferred tax
assets are only recognised if it is considered more likely than not
that there will be sufficient future taxable profits to utilise
them.
j) Dividend paid
– Dividends payable to equity shareholders are recognised when the
Company’s obligation to make payment is
established.
k) Investments
– The Company’s business is investing in financial instruments with
a view to profiting from their total return in the
form of income and capital growth. This portfolio of investments is
managed and its performance evaluated on a fair value basis, in
accordance with a documented investment strategy, and information
about the portfolio is provided on that basis to the Company’s
Board of Directors. Investments are measured at fair value with
changes in fair value recognised in profit or loss, in accordance
with the provisions of both Section 11 and Section 12 of FRS 102.
The fair value of investments is initially taken to be their cost
and is subsequently measured as follows:
- Listed
investments are valued at bid prices, or last market prices,
depending on the convention of the exchange on which they are
listed; and
- Unlisted
investments are not quoted, or are not frequently traded, and are
stated at the best estimate of fair value. The Manager’s Fair Value
Committee (“FVC”), which is independent of the Portfolio Manager’s
team, meets quarterly to determine the fair value of unlisted
investments. These are based on the principles outlined in Note 2
(b) above.
The unlisted investments are valued at fair value following a
detailed review and appropriate challenge by the Directors of the
pricing methodology proposed by the FVC.
The FVC provide a recommendation of fair values to the Directors
based on recognised valuation techniques that take account of the
cost of the investment, recent arm’s length transactions in the
same or similar investments and financial performance of the
investment since purchase. Consideration is given to the input
received from the Fidelity International analyst that covers the
company, the external valuer and Fidelity’s unlisted investments
specialist.
In accordance with the AIC SORP, the Company includes transaction
costs, incidental to the purchase or sale of investments, within
gains on investments in the capital column of the Income Statement
and has disclosed these costs in Note 10 below.
l) Derivative instruments
– When appropriate, permitted transactions in derivative
instruments are used. Derivative transactions into
which the Company may enter include long and short CFDs, futures,
options and forward currency contracts. Derivatives are classified
as other financial instruments and are initially accounted and
measured at fair value on the date the derivative contract is
entered into and subsequently measured at fair value as
follows:
- Long
and short CFDs – the difference between the strike price and the
value of the underlying shares in the contract;
- Futures
– the difference between the contract price and the quoted trade
price;
- Forward
currency contracts – valued at the appropriate quoted forward
foreign exchange rate ruling at the Balance Sheet date;
and
- Options
– the quoted trade price for the contract.
Where transactions are used to protect or enhance income, if the
circumstances support this, the income and expenses derived are
included in net income in the revenue column of the Income
Statement. Where such transactions are used to protect or enhance
capital, if the circumstances support this, the income and expenses
derived are included in gains on derivative instruments in the
capital column of the Income Statement. Any positions on such
transactions open at the year end are reflected on the Balance
Sheet at their fair value within current assets or current
liabilities.
m) Debtors
– Debtors include securities sold for future settlement, amounts
receivable on the settlement of derivatives, accrued
income, taxation recoverable and other debtors and prepayments
incurred in the ordinary course of business. If collection is
expected in one year or less (or in the normal operating cycle of
the business, if longer) they are classified as current assets. If
not, they are presented as non-current assets. They are recognised
initially at fair value and, where applicable, subsequently
measured at amortised cost using the effective interest rate
method.
n) Amounts held at futures clearing houses and
brokers
– These are amounts held in segregated accounts as collateral on
behalf
of brokers and are carried at amortised cost.
o) Other creditors
– Other creditors include securities purchased for future
settlement, amounts payable on share repurchases, capital
gains tax payable, investment management fees, secretarial and
administration fees and other creditors and expenses accrued in the
ordinary course of business. If payment is due within one year or
less (or in the normal operating cycle of the business, if longer)
they are classified as current liabilities. If not, they are
presented as non-current liabilities. They are recognised initially
at fair value and, where applicable, subsequently measured at
amortised cost using the effective interest rate method.
p) Capital reserve
– The following are accounted for in the capital
reserve:
- Gains
and losses on the disposal of investments and derivative
instruments;
- Changes
in the fair value of investments and derivative instruments held at
the year end;
- Foreign
exchange gains and losses of a capital nature;
- Variable
investment management fees;
- Dividends
receivable which are capital in nature;
- Other
expenses which are capital in nature; and
- Taxation
charged or credited relating to items which are capital in
nature.
Technical guidance issued by the Institute of Chartered Accountants
in England and Wales in TECH 02/17BL, guidance on the
determination of realised profits and losses in the context of
distributions under the Companies Act 2006, states that changes in
the fair value of investments which are readily convertible to
cash, without accepting adverse terms at the Balance Sheet date,
can be treated as realised. Capital reserves realised and
unrealised are shown in aggregate as capital reserve in the
Statement of Changes in Equity and the Balance Sheet. At the
Balance Sheet date, the portfolio of the Company consisted of
investments listed on a recognised stock exchange and derivative
instruments contracted with counterparties having an adequate
credit rating, and the portfolio was considered to be readily
convertible to cash, with the exception of the level 3 investments
which had unrealised investment holding losses of £899,000 (2022:
losses of £188,000). See Note 17 below for further details on the
level 3 investments.
3. Income
|
Year ended
31.07.23
£’000
|
Year ended
31.07.22
£’000
|
Investment income
|
|
|
Overseas dividends
|
14,847
|
13,905
|
Overseas scrip dividends
|
266
|
114
|
Interest on securities
|
164
|
–
|
|
---------------
|
---------------
|
|
15,277
|
14,019
|
|
=========
|
=========
|
Derivative income
|
|
|
Dividends received on long CFDs
|
1,743
|
1,200
|
Interest received on CFDs
|
258
|
20
|
|
---------------
|
---------------
|
|
2,001
|
1,220
|
|
=========
|
=========
|
Other interest
|
|
|
Interest received on collateral and bank deposits
|
495
|
17
|
|
---------------
|
---------------
|
Total income
|
17,773
|
15,256
|
|
=========
|
=========
|
A special dividend of £420,000 has been recognised in capital
during the year (2022: £97,000).
4 INVESTMENT MANAGEMENT FEES
|
Year ended 31 July 2023
|
Year ended 31 July 2022
|
|
Revenue
£’000
|
Capital1
£’000
|
Total
£’000
|
Revenue
£’000
|
Capital1
£’000
|
Total
£’000
|
Investment management fees
|
2,644
|
281
|
2,925
|
2,564
|
(732)
|
1,832
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
1 For
the calculation of the variable management fee, the Company’s NAV
return was compared to the Benchmark Index return on a rolling
three year basis.
FIL Investment Services (UK) Limited is the Company’s Alternative
Investment Fund Manager and has delegated portfolio management to
FIL Investments International (“FII”). Both companies are Fidelity
group companies.
The Company charges base investment management fees to revenue at
an annual rate of 0.70% of net assets. In addition, there is
+/-0.20% variation fee based on the Company’s NAV per ordinary
share performance relative to the Company’s Benchmark Index which
is charged/credited to capital. Fees are payable monthly in arrears
and are calculated on a daily basis.
5 Other Expenses
|
Year ended
31.07.23
£’000
|
Year ended
31.07.22
£’000
|
Allocated to revenue:
|
|
|
AIC fees
|
21
|
20
|
Custody fees
|
85
|
148
|
Depositary fees
|
30
|
31
|
Directors’ expenses
|
35
|
23
|
Directors’ fees1
|
193
|
162
|
Legal and professional fees
|
161
|
109
|
Marketing expenses
|
195
|
157
|
Printing and publication expenses
|
86
|
79
|
Registrars’ fees
|
38
|
37
|
Secretarial and administration fees payable to the Investment
Manager
|
75
|
75
|
Sundry other expenses
|
21
|
19
|
Fees payable to the Company's Independent Auditor for the audit of
the Financial Statements
|
48
|
45
|
|
---------------
|
---------------
|
|
988
|
905
|
|
=========
|
=========
|
1 Details
of the breakdown of Directors’ fees are disclosed in the Directors’
Remuneration Report in the Annual Report.
6 FINANCE COSTS
|
Year ended
31.07.23
£’000
|
Year ended
31.07.22
£’000
|
Interest on bank overdrafts and collateral
|
2
|
5
|
Interest paid on CFDs1
|
1,788
|
255
|
Dividends paid on short CFDs
|
207
|
71
|
|
---------------
|
---------------
|
|
1,997
|
331
|
|
=========
|
=========
|
1 Increased
compared to prior year due to an increase in both exposure to CFDs
and interest rates.
7
Taxation on Return on Ordinary
Activities
|
Year ended 31 July 2023
|
Year ended 31 July 2022
|
|
Revenue
£’000
|
Capital
£’000
|
Total
£’000
|
Revenue
£’000
|
Capital
£’000
|
Total
£’000
|
a) Analysis of the taxation charge for the
year
|
|
|
|
|
|
|
Overseas taxation
|
1,238
|
–
|
1,238
|
1,079
|
–
|
1,079
|
Indian capital gains tax
|
–
|
2,882
|
2,882
|
–
|
1,085
|
1,085
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
Taxation charge for the year (see Note
7b)
|
1,238
|
2,882
|
4,120
|
1,079
|
1,085
|
2,164
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
b) Factors affecting the taxation charge for the
year
The taxation charge for the year is lower than the standard rate of
UK corporation tax for an investment trust company of 25.00% (2022:
19.00%). A reconciliation of the standard rate of UK corporation
tax to the taxation charge for the year is shown below:
|
Year ended 31 July 2023
|
Year ended 31 July 2022
|
|
Revenue
£’000
|
Capital
£’000
|
Total
£’000
|
Revenue
£’000
|
Capital
£’000
|
Total
£’000
|
Net return on ordinary activities before taxation
|
12,144
|
31,614
|
43,758
|
11,456
|
4,234
|
15,690
|
Net return on ordinary activities before taxation multiplied by the
blended rate of UK corporation tax of 21.01%
(2022:19.00%)
|
2,551
|
6,642
|
9,193
|
2,177
|
804
|
2,981
|
Effects of:
|
|
|
|
|
|
|
Capital gains not taxable1
|
–
|
(6,701)
|
(6,701)
|
–
|
(665)
|
(665)
|
Income not taxable
|
(3,137)
|
–
|
(3,137)
|
(2,617)
|
–
|
(2,617)
|
Excess management expenses
|
586
|
59
|
645
|
441
|
–
|
441
|
Excess interest paid
|
–
|
–
|
–
|
–
|
(139)
|
(139)
|
Expense relief for overseas taxation
|
–
|
–
|
–
|
(1)
|
–
|
(1)
|
Overseas taxation
|
1,238
|
–
|
1,238
|
1,079
|
–
|
1,079
|
Indian capital gains tax
|
–
|
2,882
|
2,882
|
–
|
1,085
|
1,085
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
Taxation charge for the year (see Note
7a)
|
1,238
|
2,882
|
4,120
|
1,079
|
1,085
|
2,164
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
1 The
Company is exempt from UK corporation tax on capital gains as it
meets the HM Revenue & Customs criteria for an investment
company set out in Section 1159 of the Corporation Tax Act
2010.
c) Deferred taxation
A deferred tax asset of £8,626,000 (2022: £7,858,000), in respect
of excess management expenses of £32,235,000 (2022: £29,162,000)
and excess interest paid of £2,271,000 (2022: £2,271,000), has not
been recognised as it is unlikely that there will be sufficient
future taxable profits to utilise these expenses.
The UK corporation tax rate increased from 19.00% to 25.00% from
1 April 2023. The rate of 25.00% has
been applied to calculate the unrecognised deferred tax asset for
the current year (2022: 25.00%).
8
Return per Ordinary Share
|
Year ended
31.07.23
|
Year ended
31.07.22
|
Revenue return per ordinary share
|
15.17p
|
14.21p
|
Capital return per ordinary share
|
39.95p
|
4.31p
|
|
---------------
|
---------------
|
Total return per ordinary share
|
55.12p
|
18.52p
|
|
=========
|
=========
|
The return per ordinary share is based on the net return on
ordinary activities after taxation for the year divided by the
weighted average number of ordinary shares in issue during the
year, as shown below:
|
£’000
|
£’000
|
Net revenue return on ordinary activities after taxation
|
10,906
|
10,377
|
Net capital return on ordinary activities after taxation
|
28,732
|
3,149
|
Net total return on ordinary activities after taxation
|
39,638
|
13,526
|
|
=========
|
=========
|
|
Number
|
Number
|
Weighted average number of ordinary shares held outside of
Treasury
|
71,912,335
|
73,039,011
|
|
=========
|
=========
|
9 Dividends Paid to Shareholders
|
Year ended
31.07.23
£’000
|
Year ended
31.07.22
£’000
|
Dividend paid
|
|
|
Dividend of 14.00 pence per ordinary share paid for the year ended
31 July 2022
|
10,066
|
–
|
Dividend of 8.80 pence per ordinary share paid for the year ended
31 July 2021
|
–
|
6,440
|
|
---------------
|
---------------
|
|
10,066
|
6,440
|
|
=========
|
=========
|
Dividend proposed
|
|
|
Dividend proposed of 14.50 pence per ordinary share for the year
ended 31 July 2023
|
10,415
|
–
|
Dividend proposed of 14.00 pence per ordinary share for the year
ended 31 July 2022
|
–
|
10,086
|
|
---------------
|
---------------
|
|
10,415
|
10,086
|
|
=========
|
=========
|
The Directors have proposed the payment of a dividend for the year
ended 31 July 2023 of 14.50 pence per ordinary share which is subject
to approval by shareholders at the Annual General Meeting on
29 November 2023 and has not been
included as a liability in these Financial Statements. The dividend
will be paid on 6 December 2023 to
shareholders on the register at the close of business on
3 November 2023 (ex-dividend date
2 November 2023).
10 Investments at Fair Value through Profit or
Loss
|
2023
£’000
|
2022
£’000
|
Listed investments
|
376,751
|
337,254
|
Unlisted investments
|
880
|
1,591
|
|
---------------
|
---------------
|
Investments at fair value
|
377,631
|
338,845
|
|
=========
|
=========
|
Opening book cost
|
336,727
|
321,813
|
Opening investment holding gains
|
2,118
|
28,412
|
|
---------------
|
---------------
|
Opening fair value
|
338,845
|
350,225
|
|
=========
|
=========
|
Movements in the year
|
|
|
Purchases at cost
|
209,419
|
165,463
|
Sales – proceeds
|
(199,658)
|
(179,551)
|
Gains on investments
|
29,025
|
2,708
|
|
---------------
|
---------------
|
Closing fair value
|
377,631
|
338,845
|
|
=========
|
=========
|
Closing book cost
|
374,514
|
336,727
|
Closing investment holding gains
|
3,117
|
2,118
|
|
---------------
|
---------------
|
Closing fair value
|
377,631
|
338,845
|
|
=========
|
=========
|
The Company received £199,658,000 (2022: £179,551,000) from
investments sold in the year. The book cost of these investments
when they were purchased was £171,632,000 (2022: £150,549,000).
These investments have been revalued over time and until they were
sold any unrealised gains/losses were included in the fair value of
the investments.
Investment transaction costs
Transaction costs incurred in the acquisition and disposal of
investments, which are included in the gains on the investments
above, were as follows:
|
Year ended
31.07.23
£’000
|
Year ended
31.07.22
£’000
|
Purchases transaction costs
|
311
|
245
|
Sales transaction costs
|
416
|
390
|
|
---------------
|
---------------
|
|
727
|
635
|
|
=========
|
=========
|
The portfolio turnover rate of the year was 56.6% (2022:
49.6%).
11 Derivative Instruments
|
Year ended
31.07.23
£’000
|
Year ended
31.07.22
£’000
|
Gains/(losses) on derivative
instruments
|
|
|
Realised gains/(losses) on long CFD positions closed
|
393
|
(3,796)
|
Realised (losses)/gains on short CFD positions closed
|
(876)
|
2,584
|
Realised losses on futures contracts closed
|
(109)
|
(1,222)
|
Realised gains on options contracts closed
|
951
|
193
|
Realised gains on forward currency contracts
|
118
|
126
|
Movement in investment holding gains on long CFDs
|
1,016
|
464
|
Movement in investment holding losses on short CFDs
|
(261)
|
(451)
|
Movement in investment holding gains on futures
|
270
|
184
|
Movement in investment holding gains on options
|
233
|
49
|
Movement in investment holding gains on forward currency
contracts
|
46
|
54
|
|
---------------
|
---------------
|
|
1,781
|
(1,815)
|
|
=========
|
=========
|
|
2023
Fair value
£’000
|
2022
Fair value
£’000
|
Derivative instruments recognised on the Balance
Sheet
|
|
|
Derivative instrument assets
|
1,758
|
972
|
Derivative instrument liabilities
|
(1,665)
|
(1,302)
|
|
---------------
|
---------------
|
|
93
|
(330)
|
|
=========
|
=========
|
|
2023
|
2022
|
|
Fair value
£’000
|
Asset
exposure
£’000
|
Fair value
£’000
|
Asset
exposure
£’000
|
At the year end the Company held the following derivative
instruments:
|
|
|
|
|
Long CFDs
|
798
|
44,089
|
(218)
|
29,861
|
Long future
|
172
|
4,061
|
(88)
|
3,997
|
Put options
|
(156)
|
1,466
|
–
|
–
|
Short CFDs
|
(536)
|
10,586
|
(275)
|
7,277
|
Short future
|
(10)
|
1,292
|
(20)
|
682
|
Call options
|
(175)
|
1,705
|
317
|
3,034
|
Forward currency contracts
|
–
|
–
|
(46)
|
–
|
|
---------------
|
---------------
|
---------------
|
---------------
|
|
93
|
63,199
|
(330)
|
44,851
|
|
=========
|
=========
|
=========
|
=========
|
12 Debtors
|
2023
£’000
|
2022
£’000
|
Securities sold for future settlement
|
1,366
|
1,848
|
Amounts receivable on settlement of derivatives
|
162
|
–
|
Accrued income
|
1,572
|
1,991
|
Taxation recoverable
|
315
|
640
|
Other debtors and prepayments
|
141
|
89
|
|
---------------
|
---------------
|
|
3,556
|
4,568
|
|
=========
|
=========
|
13 Other Creditors
|
2023
£’000
|
2022
£’000
|
Securities purchased for future settlement
|
598
|
948
|
Amount payable on share repurchases
|
–
|
276
|
Indian capital gains tax payable
|
2,355
|
2,170
|
Creditors and accruals
|
599
|
431
|
|
---------------
|
---------------
|
|
3,552
|
3,825
|
|
=========
|
=========
|
14 Share Capital
|
2023
|
2022
|
|
Number of
shares
|
£’000
|
Number of
shares
|
£’000
|
Issued, allotted and fully paid
|
|
|
|
|
Ordinary shares of 25 pence each held outside of
Treasury
|
|
|
|
|
Beginning of the year
|
72,398,336
|
18,100
|
73,178,879
|
18,295
|
Ordinary shares repurchased into Treasury
|
(569,000)
|
(142)
|
(780,543)
|
(195)
|
|
---------------
|
---------------
|
---------------
|
---------------
|
End of the year
|
71,829,336
|
17,958
|
72,398,336
|
18,100
|
|
=========
|
=========
|
=========
|
=========
|
Ordinary shares of 25 pence each held in
Treasury1
|
|
|
|
|
Beginning of the year
|
3,182,553
|
795
|
2,402,010
|
600
|
Ordinary shares repurchased into Treasury
|
569,000
|
142
|
780,543
|
195
|
|
---------------
|
---------------
|
---------------
|
---------------
|
End of the year
|
3,751,553
|
937
|
3,182,553
|
795
|
|
=========
|
=========
|
=========
|
=========
|
Total share capital
|
|
18,895
|
|
18,895
|
|
|
=========
|
|
=========
|
1 Ordinary
shares held in Treasury carry no rights to vote, to receive a
dividend or to participate in a winding up of the
Company.
The cost of ordinary shares repurchased into Treasury during the
year was £2,618,000 (2022: £3,527,000).
15 Capital and Reserves
|
Share
capital
£’000
|
Share
premium
account
£’000
|
Capital
redemption
reserve
£’000
|
Other non-
distributable
reserve
£’000
|
Other
reserve
£’000
|
Capital
reserve
£’000
|
Revenue
reserve
£’000
|
Total
shareholders’
funds
£’000
|
At 1 August 2022
|
18,895
|
50,501
|
3,197
|
7,367
|
–
|
273,448
|
14,215
|
367,623
|
Gains on investments (see Note 10)
|
–
|
–
|
–
|
–
|
–
|
29,025
|
–
|
29,025
|
Gains on derivative instruments (see Note 11)
|
–
|
–
|
–
|
–
|
–
|
1,781
|
–
|
1,781
|
Foreign exchange gains
|
–
|
–
|
–
|
–
|
–
|
1,089
|
–
|
1,089
|
Investment management fees (see Note 4)
|
–
|
–
|
–
|
–
|
–
|
(281)
|
–
|
(281)
|
Indian capital gains tax (see Note 7)
|
–
|
–
|
–
|
–
|
–
|
(2,882)
|
–
|
(2,882)
|
Revenue return on ordinary activities after taxation for the
year
|
–
|
–
|
–
|
–
|
–
|
–
|
10,906
|
10,906
|
Dividend paid to shareholders (see Note 9)
|
–
|
–
|
–
|
–
|
–
|
–
|
(10,066)
|
(10,066)
|
Repurchase of ordinary shares (see Note 14)
|
–
|
–
|
–
|
–
|
–
|
(2,618)
|
–
|
(2,618)
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
At 31 July 2023
|
18,895
|
50,501
|
3,197
|
7,367
|
–
|
299,562
|
15,055
|
394,577
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
At 1 August 2021
|
18,895
|
50,501
|
3,197
|
7,367
|
719
|
273,107
|
10,278
|
364,064
|
Gains on investments (see Note 10)
|
–
|
–
|
–
|
–
|
–
|
2,708
|
–
|
2,708
|
Losses on derivative instruments (see Note 11)
|
–
|
–
|
–
|
–
|
–
|
(1,815)
|
–
|
(1,815)
|
Foreign exchange gains
|
–
|
–
|
–
|
–
|
–
|
2,609
|
–
|
2,609
|
Investment management fees (see Note 4)
|
–
|
–
|
–
|
–
|
–
|
732
|
–
|
732
|
Indian capital gains tax (see Note 7)
|
–
|
–
|
–
|
–
|
–
|
(1,085)
|
–
|
(1,085)
|
Revenue return on ordinary activities after taxation for the
year
|
–
|
–
|
–
|
–
|
–
|
–
|
10,377
|
10,377
|
Dividend paid to shareholders (see Note 9)
|
–
|
–
|
–
|
–
|
–
|
–
|
(6,440)
|
(6,440)
|
Repurchase of ordinary shares (see Note 14)
|
–
|
–
|
–
|
–
|
(719)
|
(2,808)
|
–
|
(3,527)
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
At 31 July 2022
|
18,895
|
50,501
|
3,197
|
7,367
|
–
|
273,448
|
14,215
|
367,623
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
=========
|
The capital reserve balance at 31 July
2023 includes investment holding gains of £3,117,000 (2022:
gains of £2,118,000) as detailed in Note 10 above. See Note 2 (p)
above for further details. The revenue and capital reserves are
distributable by way of dividend.
16 Net Asset Value per Ordinary Share
The calculation of the net asset value per ordinary share is based
on the total shareholders’ funds divided by the number of ordinary
shares held outside of Treasury.
|
2023
|
2022
|
Total shareholders’ funds
|
£394,577,000
|
£367,623,000
|
Ordinary shares held outside of Treasury at the year end
|
71,829,336
|
72,398,336
|
Net asset value per ordinary share
|
549.33p
|
507.78p
|
|
===========
|
===========
|
It is the Company’s policy that shares held in Treasury will only
be reissued at net asset value per ordinary share or at a premium
to net asset value per ordinary share and, therefore, shares held
in Treasury have no dilutive effect.
17 Financial Instruments
Management of risk
The Company’s investing activities in pursuit of its investment
objective involve certain inherent risks. The Board confirms that
there is an ongoing process for identifying, evaluating and
managing the risks faced by the Company. The Board with the
assistance of the Manager, has developed a risk matrix which, as
part of the internal control process, identifies the risks that the
Company faces. Principal risks identified are: economic, political
and market; investment performance (including the use of
derivatives and gearing); cybercrime and information security;
discount management; key person; environmental, social and
governance (“ESG”); business continuity and operational; and
shareholder relationships. Other risks identified are tax and
regulatory risks. Risks are identified and graded in this process,
together with steps taken in mitigation, and are updated and
reviewed on an ongoing basis. These risks and how they are
identified, evaluated and managed are shown above.
This Note refers to the identification, measurement and management
of risks potentially affecting the value of financial instruments.
The Company’s financial instruments comprise:
- Equity
shares (listed and unlisted), equity linked notes and corporate
bonds held in accordance with the Company’s investment objective
and policies;
- Derivative
instruments which comprise CFDs, forward currency contracts,
futures and options on listed stocks and equity indices;
and
- Cash,
liquid resources and short-term debtors and creditors that arise
from its operations.
The risks identified arising from the Company’s financial
instruments are market price risk (which comprises interest rate
risk, foreign currency risk and other price risk), liquidity risk,
counterparty risk, credit risk and derivative instruments risk. The
Board reviews and agrees policies for managing each of these risks,
which are summarised below. These policies are consistent with
those followed last year.
Market price risk
Interest rate risk
The Company finances its operations through its share capital and
reserves. In addition, the Company has gearing through the use of
derivative instruments. The level of gearing is reviewed regularly
by the Board and the Portfolio Manager. The Company is exposed to a
financial risk arising as a result of any increases in interest
rates associated with the funding of the derivative
instruments.
Interest rate risk exposure
The values of the Company’s financial instruments that are exposed
to movements in interest rates are shown below:
|
2023
£’000
|
2022
£’000
|
Exposure to financial instruments that bear
interest
|
|
|
Long CFDs – exposure less fair value
|
43,291
|
30,079
|
|
---------------
|
---------------
|
Exposure to financial instruments that earn
interest
|
|
|
Cash at bank
|
13,029
|
25,368
|
Short CFDs – exposure plus fair value
|
10,050
|
7,002
|
Amounts held at futures clearing houses and brokers
|
3,820
|
2,997
|
|
---------------
|
---------------
|
|
26,899
|
35,367
|
|
=========
|
=========
|
Net exposure to financial instruments that (bear)/earn
interest
|
(16,392)
|
5,288
|
|
=========
|
=========
|
Foreign currency risk
The Company’s net return on ordinary activities after taxation for
the year and its net assets can be affected by foreign exchange
rate movements because the Company has income, assets and
liabilities which are denominated in currencies other than the
Company’s functional currency which is UK sterling. The Portfolio
Manager may seek to manage exposure to currency movements by using
forward and spot foreign exchange contracts. The Company can also
be subject to short-term exposure to exchange rate movements, for
example, between the date when an investment is purchased or sold
and the date when settlement of the transaction occurs.
Three principal areas have been identified where foreign currency
risk could impact the Company:
- Movements
in currency exchange rates affecting the value of investments and
derivative instruments;
- Movements
in currency exchange rates affecting short-term timing differences;
and
- Movements
in currency exchange rates affecting income received.
Currency exposure of financial assets
The currency exposure profile of the Company’s financial assets is
shown below:
|
2023
|
Currency
|
Investments
at fair value
£’000
|
Long
exposure to
derivative
instruments1
£’000
|
Debtors2
£’000
|
Cash at
bank
£’000
|
Total
£’000
|
Hong Kong dollar
|
105,426
|
28,575
|
1,517
|
89
|
135,607
|
Indian rupee
|
82,090
|
–
|
3,260
|
1,351
|
86,701
|
US dollar
|
27,358
|
14,980
|
2,077
|
11,289
|
55,704
|
Indonesian rupiah
|
51,868
|
–
|
–
|
–
|
51,868
|
South Korean won
|
33,540
|
12
|
7
|
–
|
33,559
|
Australian dollar
|
19,017
|
3,303
|
–
|
213
|
22,533
|
Singapore dollar
|
12,934
|
2,746
|
–
|
–
|
15,680
|
Taiwan dollar
|
14,861
|
–
|
377
|
–
|
15,238
|
Chinese renminbi
|
14,109
|
–
|
–
|
87
|
14,196
|
Philippine peso
|
4,361
|
–
|
–
|
–
|
4,361
|
Malaysian ringgit
|
3,832
|
–
|
–
|
–
|
3,832
|
Sri Lankan rupee
|
3,423
|
–
|
–
|
–
|
3,423
|
Other overseas currencies
|
4,812
|
–
|
11
|
–
|
4,823
|
UK sterling
|
–
|
–
|
127
|
–
|
127
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
|
377,631
|
49,616
|
7,376
|
13,029
|
447,652
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
1 The
exposure to the market of long CFDs, long futures and put
options.
2 Debtors
include amounts held at futures clearing houses and
brokers.
|
2022
|
Currency
|
Investments
at fair value
£’000
|
Long
exposure to
derivative
instruments1
£’000
|
Debtors2
£’000
|
Cash at
bank
£’000
|
Total
£’000
|
Hong Kong dollar
|
90,764
|
25,443
|
1,318
|
287
|
117,812
|
Indian rupee
|
87,206
|
–
|
3,783
|
620
|
91,609
|
US dollar
|
12,367
|
9,783
|
1,063
|
23,801
|
47,014
|
Indonesian rupiah
|
41,649
|
–
|
4
|
–
|
41,653
|
South Korean won
|
31,895
|
–
|
68
|
6
|
31,969
|
Taiwan dollar
|
19,940
|
–
|
1,059
|
64
|
21,063
|
Australian dollar
|
19,035
|
–
|
–
|
–
|
19,035
|
Chinese renminbi
|
13,063
|
–
|
–
|
97
|
13,160
|
Singapore dollar
|
11,149
|
1,666
|
–
|
–
|
12,815
|
Philippine peso
|
4,810
|
(46)
|
33
|
–
|
4,797
|
Sri Lankan rupee
|
3,109
|
–
|
148
|
–
|
3,257
|
Vietnamese dong
|
1,173
|
–
|
–
|
493
|
1,666
|
Other overseas currencies
|
2,685
|
–
|
–
|
–
|
2,685
|
UK sterling
|
–
|
–
|
89
|
–
|
89
|
|
---------------
|
---------------
|
---------------
|
---------------
|
---------------
|
|
338,845
|
36,846
|
7,565
|
25,368
|
408,624
|
|
=========
|
=========
|
=========
|
=========
|
=========
|
1 The
exposure to the market of long CFDs, long futures and call option
after the netting of the forward currency contract.
2 Debtors
include amounts held at futures clearing houses and
brokers.
Currency exposure of financial
liabilities
The Company finances its investment activities principally through
its ordinary share capital and reserves. The Company’s financial
liabilities comprise short positions on derivative instruments and
other payables. The currency profile of these financial liabilities
is shown below:
|
2023
|
Currency
|
Short
exposure to
derivative
instruments1
£’000
|
Other
creditors
£’000
|
Total
£’000
|
US dollar
|
12,957
|
233
|
13,190
|
Indian rupee
|
–
|
2,355
|
2,355
|
Hong Kong dollar
|
626
|
41
|
667
|
Korean won
|
–
|
326
|
326
|
Indonesian rupiah
|
–
|
64
|
64
|
Singapore dollar
|
–
|
1
|
1
|
UK sterling
|
–
|
532
|
532
|
|
---------------
|
---------------
|
---------------
|
|
13,583
|
3,552
|
17,135
|
|
=========
|
=========
|
=========
|
1 The
exposure to the market of short CFDs, short futures and call
options.
|
2022
|
Currency
|
Short
exposure to
derivative
instruments1
£’000
|
Other
creditors
£’000
|
Total
£’000
|
US dollar
|
5,091
|
7
|
5,098
|
Indian rupee
|
682
|
2,744
|
3,426
|
Hong Kong dollar
|
2,186
|
311
|
2,497
|
Philippine peso
|
–
|
27
|
27
|
Malaysian ringgit
|
–
|
25
|
25
|
Taiwan dollar
|
–
|
18
|
18
|
UK sterling
|
–
|
693
|
693
|
|
---------------
|
---------------
|
---------------
|
|
7,959
|
3,825
|
11,784
|
|
=========
|
=========
|
=========
|
1 The
exposure to the market of short CFDs and short futures.
Other price risk
Other price risk arises mainly from uncertainty about future prices
of financial instruments used in the Company’s business. It
represents the potential loss the Company might suffer through
holding market positions in the face of price movements.
The Board meets quarterly to consider the asset allocation of the
portfolio and the risk associated with particular industry sectors
within the parameters of the investment objective.
The Portfolio Manager is responsible for actively monitoring the
existing portfolio selected in accordance with the overall asset
allocation parameters described above and seeks to ensure that
individual stocks also meet an acceptable risk/reward profile.
Other price risks arising from derivative positions, mainly due to
the underlying exposures, are estimated using Value at Risk and
Stress Tests as set out in the Company’s internal Risk Management
Process Document.
Liquidity risk
Liquidity risk is the risk that the Company will encounter
difficulties in meeting obligations associated with financial
liabilities. The Company’s assets mainly comprise readily
realisable securities and derivative instruments which can be sold
easily to meet funding commitments if necessary. Short-term
flexibility, if required, is achieved by the use of a bank
overdraft.
Liquidity risk exposure
At 31 July 2023, the undiscounted
gross cash outflows of the financial liabilities were all repayable
within one year and consisted of derivative instrument liabilities
of £1,665,000 (2022: £1,302,000) and other creditors of £3,552,000
(2022: £3,825,000).
Counterparty risk
Certain derivative instruments in which the Company may invest are
not traded on an exchange but instead will be traded between
counterparties based on contractual relationships, under the terms
outlined in the International Swaps and Derivatives Association’s
(“ISDA”) market standard derivative legal documentation. These are
known as Over the Counter (“OTC”) trades. As a result, the Company
is subject to the risk that a counterparty may not perform its
obligations under the related contract. In accordance with the risk
management process which the Manager employs, the Manager will seek
to minimise such risk by only entering into transactions with
counterparties which are believed to have an adequate credit rating
at the time the transaction is entered into, by ensuring that
formal legal agreements covering the terms of the contract are
entered into in advance, and through adopting a counterparty risk
framework which measures, monitors and manages counterparty risk by
the use of internal and external credit agency ratings and by
evaluating derivative instrument credit risk exposure.
For OTC and exchange traded derivative transactions, collateral is
used to reduce the risk of both parties to the contract. Collateral
is managed on a daily basis for all relevant transactions. At
31 July 2023, £793,000 (2022:
£254,000) was held by the brokers in cash denominated in US dollars
in a segregated collateral account on behalf of the Company, to
reduce the credit risk exposure of the Company. This collateral
comprised: J.P. Morgan Securities plc £436,000 (2022: £213,000),
Goldman Sachs International £233,000 (2022: £nil), HSBC Bank plc
£124,000 (2022: £nil) and Morgan Stanley & Co International plc
£nil (2022: £41,000). £3,820,000 (2022: £2,997,000), shown as
amounts held at futures clearing houses and brokers on the Balance
Sheet, was held by the Company in a segregated collateral account,
on behalf of the brokers, to reduce the credit risk exposure of the
brokers. This collateral is comprised of: UBS AG £3,346,000 (2022:
£2,574,000) in cash, Morgan Stanley & Co International plc
£474,000 (2022: £nil) in cash and HSBC Bank Plc £nil (2022:
£423,000) in cash.
Credit risk
Financial instruments may be adversely affected if any of the
institutions with which money is deposited suffer insolvency or
other financial difficulties. All transactions are carried out with
brokers that have been approved by the Manager and are settled on a
delivery versus payment basis. Limits are set on the amount that
may be due from any one broker and are kept under review by the
Manager. Exposure to credit risk arises on unsettled security
transactions and derivative instrument contracts and cash at
bank.
Derivative instruments risk
The risks and risk management processes which result from the use
of derivative instruments, are set out in a documented Risk
Management Process Document. Derivative instruments are used by the
Manager for the following purposes:
- to
gain unfunded long exposure to equity markets, sectors or single
stocks. Unfunded exposure is exposure gained without an initial
flow of capital;
- to
hedge equity market risk using derivatives with the intention of at
least partially mitigating losses in the exposures of the Company’s
portfolio as a result of falls in the equity market; and
- to
position short exposures in the Company’s portfolio. These
uncovered exposures benefit from falls in the prices of shares
which the Portfolio Manager believes to be over valued. These
positions, therefore, distinguish themselves from other short
exposures held for hedging purposes since they are expected to add
risk to the portfolio.
RISK SENSITIVITY ANALYSIS
Interest rate risk sensitivity analysis
Based on the financial instruments held and interest rates at
31 July 2023, an increase of 1.00% in
interest rates throughout the year, with all other variables held
constant, would have decreased the net return on ordinary
activities after taxation for the year and decreased the net assets
of the Company by £164,000 (2022: increased the net return and
increased the net assets by £53,000). A decrease of 1.00% in
interest rates throughout the year would have had an equal but
opposite effect.
Foreign currency risk sensitivity
analysis
Based on the financial instruments held and currency exchange rates
as at the Balance Sheet date, with all other variables held
constant, a 10% strengthening of the UK sterling exchange rate
against other currencies would have decreased the Company’s net
return on ordinary activities after taxation for the year and
decreased the net assets (2022: decreased the net return and
decreased the net assets) by the following amounts:
Currency
|
2023
£’000
|
2022
£’000
|
Hong Kong dollar
|
12,267
|
10,483
|
Indian rupee
|
7,668
|
8,017
|
Indonesian rupiah
|
4,709
|
3,787
|
US dollar
|
3,865
|
3,811
|
South Korean won
|
3,021
|
2,906
|
Australian dollar
|
2,048
|
1,730
|
Singapore dollar
|
1,425
|
1,165
|
Taiwan dollar
|
1,385
|
1,913
|
Chinese renminbi
|
1,291
|
1,196
|
Philippine peso
|
396
|
434
|
Malaysian ringgit
|
348
|
70
|
Sri Lankan rupee
|
311
|
296
|
Other overseas currencies
|
438
|
322
|
|
---------------
|
---------------
|
|
39,172
|
36,130
|
|
=========
|
=========
|
Based on the financial instruments held and currency exchange rates
as at the Balance Sheet date, with all other variables held
constant, a 10% weakening of the UK sterling exchange rate against
other currencies would have increased the Company’s net return on
ordinary activities after taxation for the year and increased the
net assets (2022: increased the net return and increased the net
assets) by the following amounts:
Currency
|
2023
£’000
|
2022
£’000
|
Hong Kong dollar
|
14,993
|
12,813
|
Indian rupee
|
9,372
|
9,798
|
Indonesian rupiah
|
5,756
|
4,628
|
US dollar
|
4,724
|
4,657
|
South Korean won
|
3,693
|
3,552
|
Australian dollar
|
2,504
|
2,115
|
Singapore dollar
|
1,742
|
1,424
|
Taiwan dollar
|
1,693
|
2,338
|
Chinese renminbi
|
1,577
|
1,462
|
Philippine peso
|
485
|
530
|
Malaysian ringgit
|
426
|
86
|
Sri Lankan rupee
|
380
|
362
|
Other overseas currencies
|
535
|
395
|
|
---------------
|
---------------
|
|
47,880
|
44,160
|
|
=========
|
=========
|
Other price risk – exposure to investments sensitivity
analysis
Based on the listed investments held and share prices at
31 July 2023, an increase of 10% in
share prices, with all other variables held constant, would have
increased the Company’s net return on ordinary activities after
taxation for the year and increased the net assets of the Company
by £37,675,000 (2022: increased the net return and increased the
net assets by £33,725,000). A decrease of 10% in share prices would
have had an equal and opposite effect.
An increase of 10% in the valuation of unlisted investments held at
31 July 2023 would have increased the
Company’s net return on ordinary activities after taxation for the
year and increased the net assets of the Company by £88,000 (2022:
increased the net return and increased the net assets by £159,000).
A decrease of 10% in the valuation would have had an equal and
opposite effect.
Other price risk – net exposure to derivative instruments
sensitivity analysis
Based on the derivative instruments held and share prices at
31 July 2023, an increase of 10% in
the share prices underlying the derivative instruments, with all
other variables held constant, would have increased the Company’s
net return on ordinary activities after taxation for the year and
increased the net assets of the Company by £3,603,000 (2022:
increased the net return and increased the net assets by
£2,893,000). A decrease of 10% in share prices would have had an
equal and opposite effect.
Fair Value of Financial Assets and
Liabilities
Financial assets and liabilities are stated in the Balance Sheet at
values which are not materially different to their fair values. As
explained in Notes 2 (k) and (l) above, investments and derivative
instruments are shown at fair value. In the case of cash at bank,
book value approximates to fair value due to the short maturity of
the instruments.
Fair Value Hierarchy
The Company is required to disclose the fair value hierarchy that
classifies its financial instruments measured at fair value at one
of three levels, according to the relative reliability of the
inputs used to estimate the fair values.
Classification
|
Input
|
Level 1
|
Valued using quoted prices in active markets for identical
assets
|
Level 2
|
Valued by reference to inputs other than quoted prices included in
level 1 that are observable (i.e. developed using market data) for
the asset or liability, either directly or indirectly
|
Level 3
|
Valued by reference to valuation techniques using inputs that are
not based on observable market data
|
Categorisation within the hierarchy has been determined on the
basis of the lowest level input that is significant to the fair
value measurement of the relevant asset. The valuation techniques
used by the Company are explained in Notes 2 (k) and (l) above. The
table below sets out the Company’s fair value hierarchy:
|
2023
|
Financial assets at fair value through profit or loss
|
Level 1
£’000
|
Level 2
£’000
|
Level 3
£’000
|
Total
£’000
|
Investments
|
367,312
|
9,439
|
880
|
377,631
|
Derivative instrument assets
|
172
|
1,586
|
–
|
1,758
|
|
---------------
|
---------------
|
---------------
|
---------------
|
|
367,484
|
11,025
|
880
|
379,389
|
|
=========
|
=========
|
=========
|
=========
|
Financial liabilities at fair value through profit or
loss
|
|
|
|
|
Derivative instrument liabilities
|
(341)
|
(1,324)
|
–
|
(1,665)
|
|
=========
|
=========
|
=========
|
=========
|
|
2022
|
Financial assets at fair value through profit or loss
|
Level 1
£’000
|
Level 2
£’000
|
Level 3
£’000
|
Total
£’000
|
Investments
|
330,119
|
7,135
|
1,591
|
338,845
|
Derivative instrument assets
|
317
|
655
|
–
|
972
|
|
---------------
|
---------------
|
---------------
|
---------------
|
|
330,436
|
7,790
|
1,591
|
339,817
|
|
=========
|
=========
|
=========
|
=========
|
Financial liabilities at fair value through profit or
loss
|
|
|
|
|
Derivative instrument liabilities
|
(108)
|
(1,194)
|
–
|
(1,302)
|
|
=========
|
=========
|
=========
|
=========
|
The table below sets out the movements in level 3 financial
instruments during the year:
|
Year ended
31.07.23
£’000
|
Year ended
31.07.22
£’000
|
Beginning of the year
|
1,591
|
1,722
|
Movement in investment holding losses
|
(711)
|
(131)
|
|
---------------
|
---------------
|
End of the year
|
880
|
1,591
|
|
=========
|
=========
|
Below are details of the four investments which fall into level 3
of which the first three investments are unlisted and the last
investment is suspended from trading.
Eden Biologics
Eden Biologics develops biosimilars and is also engaged in
providing process development and contract manufacturing solutions
to the biopharmaceutical industry and is an unlisted company. On
26 February 2018, the company
voluntarily delisted from the Taipei Exchange. The valuation at
31 July 2023 is based on the
company’s financial information, the macro-environment and a
weighted average following a scenario-based approach. As at
31 July 2023, its fair value was
£40,000 (2022: £317,000).
Chime Biologics
Chime Biologics is a China-based
Contract Development and Manufacturing Organization (CDMO) that
provides a solution supporting customers from early-stage
biopharmaceutical development through to late-stage clinical and
commercial manufacturing and is an unlisted company. The valuation
at 31 July 2023 is based on the
company’s financial information, the macro-environment and the
Probability-Weighted Expected Return Model (PWERM). As at
31 July 2023, its fair value was
£69,000 (2022: £73,000).
Tuhu Car
Tuhu Car is an online retailer of auto spare parts and is an
unlisted company. The valuation at 31 July
2023 is based on the company’s financial information, the
macro-environment and benchmarking the position to a range of
comparable market data. As at 31 July
2023, its fair value was £771,000 (2022:
£1,201,000).
Salt Lake Potash
Salt Lake Potash is a mineral exploration company. The company was
suspended from trading on the Australian Stock Exchange on
27 July 2021 and in October 2021 it announced that it would be
entering voluntary administration. As at 31
July 2023, its fair value was £nil (2022: £nil).
18 Capital Resources and Gearing
The Company does not have any externally imposed capital
requirements. The financial resources of the Company comprise its
share capital and reserves, as disclosed in the Balance Sheet above
and any gearing, which is managed by the use of derivative
instruments. Financial resources are managed in accordance with the
Company’s investment policy and in pursuit of its investment
objective, both of which are detailed in the in the Annual Report.
The principal risks and their management are disclosed above and in
Note 17 above.
The Company’s gross and net gearing at the year end is set out
below:
|
2023
|
|
Gross gearing
|
Net gearing
|
|
Asset
exposure
£’000
|
%1
|
Asset
exposure
£’000
|
%1
|
Investments
|
377,631
|
95.7
|
377,631
|
95.7
|
Long CFDs
|
44,089
|
11.2
|
44,089
|
11.2
|
Long future
|
4,061
|
1.0
|
4,061
|
1.0
|
Put options
|
1,466
|
0.4
|
1,466
|
0.4
|
|
---------------
|
---------------
|
---------------
|
---------------
|
Total long exposures
|
427,247
|
108.3
|
427,247
|
108.3
|
|
=========
|
=========
|
=========
|
=========
|
Short CFDs
|
10,586
|
2.7
|
(10,586)
|
(2.7)
|
Call options
|
1,705
|
0.4
|
(1,705)
|
(0.4)
|
Short future
|
1,292
|
0.3
|
(1,292)
|
(0.3)
|
|
---------------
|
---------------
|
---------------
|
---------------
|
Gross asset exposure/net market
exposure
|
440,830
|
111.7
|
413,664
|
104.9
|
|
=========
|
=========
|
=========
|
=========
|
Shareholders’ funds
|
394,577
|
|
394,577
|
|
|
=========
|
|
=========
|
|
Gearing2
|
|
11.7%
|
|
4.9%
|
|
|
=========
|
|
=========
|
1 Asset
exposure to the market expressed as a percentage of shareholders’
funds.
2 Gearing
is the amount by which gross asset exposure/net market exposure
exceeds shareholders’ funds expressed as a percentage of
shareholders’ funds.
|
2022
|
|
Gross gearing
|
Net gearing
|
|
Asset
exposure
£’000
|
%1
|
Asset
exposure
£’000
|
%1
|
Investments
|
338,845
|
92.2
|
338,845
|
92.2
|
Long CFDs
|
29,861
|
8.1
|
29,861
|
8.1
|
Long future
|
3,997
|
1.1
|
3,997
|
1.1
|
Put options
|
3,034
|
0.8
|
3,034
|
0.8
|
|
---------------
|
---------------
|
---------------
|
---------------
|
Total long exposures
|
375,737
|
102.2
|
375,737
|
102.2
|
|
=========
|
=========
|
=========
|
=========
|
Short CFDs
|
7,277
|
2.0
|
(7,277)
|
(2.0)
|
Short future
|
682
|
0.2
|
(682)
|
(0.2)
|
|
---------------
|
---------------
|
---------------
|
---------------
|
Gross asset exposure/net market
exposure
|
383,696
|
104.4
|
367,778
|
100.0
|
|
=========
|
=========
|
=========
|
=========
|
Shareholders’ funds
|
367,623
|
|
367,623
|
|
|
=========
|
|
=========
|
|
Gearing2
|
|
4.4%
|
|
–
|
|
|
=========
|
|
=========
|
1 Asset
exposure to the market expressed as a percentage of shareholders’
funds.
2 Gearing
is the amount by which gross asset exposure/net market exposure
exceeds shareholders’ funds expressed as a percentage of
shareholders’ funds.
19 Transactions with the Manager and Related
Parties
FIL Investment Services (UK) Limited is the Company’s Alternative
Investment Fund Manager and has delegated portfolio management and
the role of company secretary to FIL Investments International
(“FII”). Both companies are Fidelity group companies.
Details of the current fee arrangements are given in the Directors’
Report in the Annual Report. During the year, management fees of
£2,925,000 (2022: £1,832,000), and secretarial and administration
fees of £75,000 (2022: £75,000) were payable to FII. At the Balance
Sheet date, management fees of £292,000 (2022: £156,000), and
secretarial and administration fees of £25,000 (2022: £25,000) were
accrued and included in other creditors. FII also provides the
Company with marketing services. The total amount payable for these
services during the year was £195,000 (2022: £157,000). At the
Balance Sheet date, marketing services of £nil (2022: £20,000) were
accrued and included in other creditors.
Disclosures of the Directors’ interests in the ordinary shares of
the Company and Director’s fees and taxable expenses relating to
reasonable travel expenses payable to the Directors are given in
the Directors’ Remuneration Report in the Annual Report. In
addition to the fees and taxable expenses disclosed in the
Directors’ Remuneration Report, £20,000 (2022: £18,000) of
employers’ National Insurance contributions were paid by the
Company. At the Balance Sheet date, Directors’ fees of £16,000
(2022: £15,000) were accrued and payable.
20 post balance sheet event
On 26 September 2023 following an
initial public offering, Tuhu Car, which was classified as a Level
3 investment as at 31 July 2023 as
set out in Note 17 above, was listed on the Hong Kong Stock
Exchange at a 2% premium to the Balance Sheet valuation.
Alternative Performance Measures
Discount/Premium
The discount/premium is considered to be an Alternative Performance
Measure. It is the difference between the NAV per ordinary share of
the Company and the ordinary share price and is expressed as a
percentage of the NAV per ordinary share. Details of the Company’s
discount/premium are on the Financial Highlights section in the
Annual Report and are both defined in the Glossary of Terms in the
Annual Report.
Gearing
Gearing (both Gross and Net) is considered to be an Alternative
Performance Measure. See Note 18 above for details of the Company’s
gearing.
Net Asset Value (“NAV”) per Ordinary
Share
The NAV per ordinary share is considered to be an Alternative
Performance Measure. See the Balance Sheet and Note 16 above for
further details.
Ongoing Charges Ratio
The ongoing charges ratio is considered to be an Alternative
Performance Measure. The ongoing charges ratio has been calculated
in accordance with guidance issued by the AIC as the total of
management fees and other expenses expressed as a percentage of the
average net assets throughout the year.
|
2023
£’000
|
2022
£’000
|
Investment management fees (£’000)
|
2,644
|
2,564
|
Other expenses (£’000)
|
988
|
905
|
|
---------------
|
---------------
|
Ongoing charges (£’000)
|
3,632
|
3,469
|
|
=========
|
=========
|
Variable management fees (£’000)
|
281
|
(732)
|
Average net assets (£’000)
|
377,729
|
366,346
|
Ongoing charges ratio
|
0.96%
|
0.95%
|
Ongoing charges ratio including variable management
fees
|
1.03%
|
0.75%
|
|
=========
|
=========
|
Revenue, Capital and Total Returns per
Share
Revenue, capital and total returns per share are considered to be
Alternative Performance Measures. See the Income Statement and Note
8 above for further details.
Total Return Performance
Total return performance is considered to be an Alternative
Performance Measure. The NAV per ordinary share total return
includes reinvestment of the dividend in the NAV of the Company on
the ex-dividend date. The ordinary share price total return
includes the reinvestment of the net dividend in the month that the
ordinary share price goes ex-dividend.
The tables below provide information relating to the NAV per
ordinary share and the ordinary share price of the Company and the
impact of the dividend reinvestments and the total returns for the
years ended 31 July 2023 and
31 July 2022.
2023
|
Net asset
value per
ordinary
share
|
Ordinary
share
price
|
31 July 2022
|
507.78p
|
458.00p
|
31 July 2023
|
549.33p
|
520.00p
|
Change in year
|
+8.2%
|
+13.5%
|
Impact of dividend reinvestment
|
+3.2%
|
+3.8%
|
|
---------------
|
---------------
|
Total return for the year
|
+11.4%
|
+17.3%
|
|
=========
|
=========
|
2022
|
Net asset
value per
ordinary
share
|
Ordinary
share
price
|
31 July 2021
|
497.50p
|
483.00p
|
31 July 2022
|
507.78p
|
458.00p
|
Change in year
|
+2.1%
|
-5.2%
|
Impact of dividend reinvestment
|
+1.8%
|
+1.8%
|
|
---------------
|
---------------
|
Total return for the year
|
+3.9%
|
-3.4%
|
|
=========
|
=========
|
The Annual Financial Report Announcement is not the Company's
statutory accounts. The above results for the year ended
31 July 2023 are an abridged version
of the Company's full Annual Report and Financial Statements, which
have been approved and audited with an unqualified report. The 2022
and 2023 statutory accounts received unqualified reports from the
Company's Auditor and did not include any reference to matters to
which the Auditor drew attention by way of emphasis without
qualifying the reports and did not contain a statement under s.498
of the Companies Act 2006. The financial information for 2022 is
derived from the statutory accounts for 2022 which have been
delivered to the Registrar of Companies. The 2023 Financial
Statements will be filed with the Registrar of Companies in due
course.
A copy of the above results announcement will be available on the
Company's website at
www.fidelity.co.uk/asianvalues
within two working days.
A copy of the Annual Report will shortly be submitted to the
National Storage Mechanism and will be available for inspection at:
www.morningstar.co.uk/uk/NSM
The Annual Report will be posted to shareholders later this month
and additional copies will be available from the registered office
of the Company and on the Company's website:
www.fidelity.co.uk/asianvalues where up to date
information
on the Company, including daily NAV and share prices, factsheets
and other information can also be found.
Neither the contents of the Company's website nor the contents of
any website accessible from hyperlinks on the Company's website (or
any other website) is incorporated into, or forms part of, this
announcement.
ENDS